Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8376104261102144,-2.253027071719592,0.0,0.0,0.0,8/22,6.20%,ALDH1A2;NR2F2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4;CRABP2
prerank,cation channel activity (GO:0005261),-0.5373976664687029,-1.9124850085586782,0.0,0.05620654709121665,0.095,26/94,12.73%,SLC24A3;TRPM3;NALCN;PIEZO2;MCU;ANXA2;PKD1;KCNK5;ANO6;TRPC3;PKD2;TRPM6;ABCC9;ANXA6;KCNQ4;ANO1;CALHM2;CACNA1D;CALHM5;TRPC6;TRPM4;TMEM175;CACNB2;SLC24A5;PANX1;PSEN1
prerank,metalloendopeptidase activity (GO:0004222),-0.5322339455871619,-1.8478926132652755,0.0,0.1044546450367743,0.238,24/76,11.91%,TRABD2B;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;ADAMTS10;ADAMTS6;ADAMTSL5;MMP14;MMP16;ADAMTS17;ADAMTS5;ADAM9;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ADAM19;ADAM33;IDE;MMP19;AFG3L2;ADAMTS1
prerank,sialyltransferase activity (GO:0008373),0.7884952584374428,1.8301043695774495,0.0036036036036036037,0.46151734712711134,0.312,6/20,2.39%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;ST3GAL1;ST6GALNAC2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8195318698093276,1.827160875548416,0.005253940455341506,0.16253437007520008,0.329,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8195318698093276,1.827160875548416,0.005253940455341506,0.16253437007520008,0.329,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,retinoic acid binding (GO:0001972),-0.7724858979707783,-1.8009639958482746,0.0022271714922048997,0.15618456448355775,0.423,4/12,17.08%,NR2F2;CYP26B1;RXRA;RARA
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.7020478998350865,1.7787310496979905,0.0016638935108153079,0.2671282471143335,0.552,5/30,4.06%,SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.690368729639576,1.7681750156650347,0.003194888178913738,0.2476140897195023,0.623,5/32,2.92%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.737823468005704,-1.7560527501434253,0.0,0.21885735150562233,0.617,4/13,1.84%,BMP6;BMP5;BMP7;BMP4
prerank,death receptor activity (GO:0005035),0.8335571326782844,1.7526094419038079,0.005405405405405406,0.25951989954394084,0.708,4/11,2.32%,TNFRSF19;FAS;TNFRSF25;TNFRSF11A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.5531629537577536,-1.751113040902695,0.0,0.19431879997317378,0.631,13/48,10.80%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;PKD2;TRPM6;ABCC9;SLC12A7;CALHM2;CALHM5;TRPC6;TRPM4
prerank,protein phosphatase 2A binding (GO:0051721),0.714225896595326,1.7358672438275964,0.0017421602787456446,0.2750471394835176,0.776,5/23,4.79%,MFHAS1;DAB2IP;CTTNBP2NL;FOXO1;STRN4
prerank,monocarboxylic acid binding (GO:0033293),-0.6806840603395041,-1.7275353265441837,0.007142857142857143,0.21573081791268486,0.732,7/18,23.20%,NR2F2;CYP26B1;RXRA;RARA;PSAP;NR1H4;PYGL
prerank,BMP receptor binding (GO:0070700),-0.7378246069265832,-1.7130506472191032,0.0,0.22233917300684813,0.785,4/12,1.84%,BMP6;BMP5;BMP7;BMP4
prerank,leak channel activity (GO:0022840),-0.6571132101796866,-1.7056505839129883,0.009685230024213076,0.21465705890096898,0.812,5/18,12.71%,KCNK2;NALCN;KCNK5;TMEM175;PANX1
prerank,acylglycerol lipase activity (GO:0047372),0.8166734738377329,1.7009277017906366,0.009124087591240875,0.3858937166060113,0.906,2/11,2.96%,ABHD2;LIPE
prerank,cAMP binding (GO:0030552),0.8184406579693739,1.6965894413141938,0.009727626459143969,0.3605186233355261,0.917,5/11,8.49%,PDE2A;RAPGEF2;PDE4D;RAPGEF4;PDE4B
prerank,platelet-derived growth factor binding (GO:0048407),-0.7439898139387959,-1.691331835942134,0.013953488372093023,0.22781060679448867,0.856,7/11,2.13%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,cation transmembrane transporter activity (GO:0008324),0.6122139958054824,1.6591289342700988,0.008928571428571428,0.5049601756719024,0.977,5/48,1.99%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC38A5
prerank,anion transmembrane transporter activity (GO:0008509),0.7823925340503404,1.651117956239028,0.026223776223776224,0.4990954394228366,0.984,3/12,1.25%,ABCG2;SLCO2B1;SLC39A8
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5896228323414702,1.6462307649278536,0.005891016200294551,0.48175053517145205,0.988,6/51,3.12%,SLCO1C1;SLC7A5;MFSD2A;SLCO2B1;SLC16A2;SLC22A8
prerank,protease binding (GO:0002020),-0.453570632414093,-1.6352657595610194,0.003676470588235294,0.35532666696925214,0.968,22/99,8.56%,COL1A2;COL3A1;COL1A1;TIMP2;TIMP3;CCBE1;SLC2A13;ANXA2;ATP9A;STIM1;F3;AMFR;ADAMTSL4;FAP;ECM1;LCOR;PRKN;BCL2;BDKRB2;SELENOS;LDLR;DPP4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7398474832727759,-1.6304568695109374,0.017429193899782137,0.3398920989291862,0.976,3/10,5.44%,SLC6A13;SLC6A12;SLC6A1
prerank,metallopeptidase activity (GO:0008237),-0.4385662720934271,-1.6217048399911502,0.0,0.33632099995357,0.984,27/113,11.91%,TRABD2B;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;ADAMTS10;PAPPA;ADAMTS6;ADAMTSL5;MMP14;MMP16;ANPEP;ADAMTS17;ADAMTS5;ADAM9;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;ADAM33;IDE;MMP19;AFG3L2;ADAMTS1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.6859400434795904,1.6201696766098,0.022298456260720412,0.5757390317003763,0.999,3/20,3.00%,SLC39A10;SLC39A8;SLC30A1
prerank,phospholipid transfer activity (GO:0120014),0.6912852420731841,1.6196578078137709,0.014035087719298246,0.5373380541551367,0.999,12/21,17.72%,CERT1;PLTP;PRELID2;PITPNC1;PITPNA;ABCA3;MTTP;GLTP;PLEKHA3;PITPNB;TRIAP1;C2CD2L
prerank,AMP binding (GO:0016208),-0.699632593905922,-1.6182740458435543,0.017467248908296942,0.3217487297459279,0.985,4/11,10.19%,PRKAG2;MPPED2;PFKP;PRKAG3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.51016204534329,1.6181842736165872,0.0,0.509073699852818,0.999,11/134,1.99%,SLCO1C1;SLC6A6;SLC7A5;ABCC4;SLC7A1;ABCG2;SLC1A1;MFSD2A;SLCO2B1;SLC39A8;SLC38A5
prerank,cell adhesion mediator activity (GO:0098631),0.6421092283430572,1.6138671306814274,0.026533996683250415,0.4958176173551725,0.999,7/24,11.25%,BSG;ESAM;ROBO4;DSCAML1;CNTN2;BCAM;PLXNB3
prerank,calcium channel activity (GO:0005262),-0.4537205350126472,-1.6126113356998522,0.006535947712418301,0.3172105188640581,0.987,24/84,14.04%,SLC24A3;CACNA1C;CACNA2D3;MCU;ANXA2;PKD1;CACNA2D1;TRPC3;PKD2;ANXA6;P2RX4;CACNA1D;TRPC6;CACNB4;ITGAV;TRPM4;CACNB2;TRPC4;SLC24A5;PANX1;PSEN1;CATSPER3;ORAI2;CACNB1
prerank,alanine transmembrane transporter activity (GO:0022858),0.757084548453163,1.6001532598635264,0.033391915641476276,0.5296826330518957,0.999,2/12,1.99%,SLC6A6;SLC38A5
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6958445209787347,-1.5998534406467104,0.028199566160520606,0.33164349799175835,0.991,8/12,24.11%,SULF1;SULF2;ARSI;ARSB;GNS;GALNS;ARSG;SGSH
prerank,cadherin binding (GO:0045296),0.4580098011642475,1.5986325372598362,0.0011389521640091116,0.5077805594599015,0.999,55/315,9.11%,PROM1;COBLL1;PTPRM;ITGA6;PTPRB;BSG;DOCK9;TJP1;SPTBN1;KDR;DAB2IP;MACF1;ESYT2;WASF2;BMPR2;EPN2;MRTFB;FASN;TJP2;FNBP1L;TRIM25;FLNB;F11R;STK38;PTPRJ;LRRFIP1;CDH2;CD2AP;PPFIBP1;STXBP6;CDH20;TBC1D2;CTNNB1;CTNND1;CDH8;HSP90AB1;EIF4H;BAIAP2;EPS8L2;MRE11;DBNL;STAT1;PKN2;DCHS1;CDH19;PKP4;PKM;IQGAP1;EIF3E;SPTAN1;TWF2;CLINT1;CTNNA3;SLC3A2;CAPG
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6609799130314988,-1.5884709995309743,0.024943310657596373,0.34718734397937356,0.993,8/15,13.72%,HS3ST3A1;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2;NDST2;NDST4;NDST1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6969487104462486,1.5795691470224014,0.033101045296167246,0.5729362947745033,0.999,9/17,11.50%,ATP10A;PLTP;ABCG1;PITPNC1;PITPNA;ABCA3;ABCA7;ATP10B;MTTP
prerank,lipoprotein particle binding (GO:0071813),0.6756587235239128,1.5775272266829938,0.028523489932885907,0.554673620346138,0.999,5/20,7.28%,PLTP;STAB1;SCARF1;SCARB1;LIPC
prerank,low-density lipoprotein particle binding (GO:0030169),0.6967364681145481,1.572278310980588,0.041811846689895474,0.549329861000779,0.999,5/16,7.28%,PLTP;STAB1;SCARF1;SCARB1;LIPC
prerank,solute:anion antiporter activity (GO:0140323),-0.6658066929587361,-1.5682508160922888,0.03587443946188341,0.38675852167584474,0.995,4/14,8.80%,SLC7A11;SLC26A7;SLC26A2;SLC4A2
prerank,amyloid-beta binding (GO:0001540),0.5217664442183487,1.5664848437383585,0.011235955056179775,0.5505372939247517,0.999,18/79,11.56%,ITM2A;INSR;CACNA1A;APBB2;FZD6;TGFB2;BCHE;FZD4;CLSTN1;RAMP3;EPHA4;ATP1A3;GRIA4;PFDN4;APBA2;PFDN2;AGER;GRIN2B
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6920926621002765,-1.5659526869650457,0.037199124726477024,0.37347116944727377,0.995,5/11,11.80%,ITPR1;TRPC3;TRPC6;ITPR2;TRPC4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4815013170794983,1.5603522030109094,0.00375,0.555085845197778,0.999,37/147,11.22%,DOCK4;DOCK9;FGD5;PREX2;RAPGEF2;RASGRF2;DENND3;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;ARHGEF2;KALRN;RAPGEF1;TIAM1;ABR;RIN3;DENND5B;RAPGEF3;CYTH3;DENND4C;RAPGEF4;EPS8L2;CCDC88A;SOS1;RASGRP2;RGL2;PREX1;ARHGEF5;ARHGEF7;FGD6;EIF2B1;LAMTOR5;DENND1B;EIF2B2
prerank,glycerophospholipid flippase activity (GO:0140333),0.7535935568518276,1.5585770472597182,0.03208556149732621,0.5394820076698705,0.999,6/11,9.76%,ATP10A;ATP8A1;ATP11A;ABCA3;ATP11C;ATP10B
prerank,pentosyltransferase activity (GO:0016763),-0.509815418351446,-1.5570457989568334,0.018867924528301886,0.3807620513126225,0.997,15/36,17.04%,LARGE1;PARP8;PARP3;LACC1;SIRT3;TNKS2;PARP4;PARP6;PARP11;PARP1;UPP2;QPRT;SIRT2;TIPARP;UMPS
prerank,FAD binding (GO:0071949),-0.5691462409073613,-1.555399906027525,0.023696682464454975,0.367462440612362,0.997,11/24,20.09%,MICAL3;DDO;MICAL2;PRODH;MTHFR;CRY2;MICAL1;SQOR;SQLE;AGPS;KMO
prerank,semaphorin receptor binding (GO:0030215),0.6452513996335802,1.5494204816690156,0.045454545454545456,0.5591182330586882,0.999,7/23,9.35%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7551506918163593,1.5491367068323367,0.03294573643410853,0.5390414566905198,0.999,2/11,1.14%,SGMS1;SGMS2
prerank,peptidoglycan binding (GO:0042834),0.7539403445801183,1.5443125526501307,0.04633204633204633,0.539514521975727,0.999,3/10,3.22%,PGLYRP1;NOD1;NOD2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7389761028337309,1.5441405751240556,0.04744525547445255,0.5208911238499082,0.999,3/11,2.55%,DAB2IP;MAP4K2;STK38
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6416645340799181,-1.5422459759400058,0.04,0.3866178420192296,0.999,4/15,7.78%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,phospholipase inhibitor activity (GO:0004859),-0.6968029472000778,-1.5398317586972086,0.0405982905982906,0.37556094528128825,0.999,4/10,5.72%,ANXA2;ANXA4;ANXA1;ANXA5
prerank,phosphatidylinositol binding (GO:0035091),0.5009054812313463,1.531496366973753,0.019553072625698324,0.5544781501054133,1.0,19/91,8.49%,MCF2L;HIP1;MYO1E;ESYT2;FES;HIP1R;SCARB1;EPB41;PARD3;SNX13;PITPNC1;PITPNA;PIGU;CCDC88A;ESYT1;PLEKHF2;WDFY3;FCHO2;PIGK
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6863805051255706,-1.519986128082992,0.048484848484848485,0.4177771298911302,0.999,8/10,25.86%,AUH;ECHDC2;ECHDC1;ECHDC3;EHHADH;ECI1;HADHA;ECHS1
prerank,Toll-like receptor binding (GO:0035325),0.7248316427378004,1.5197771129791326,0.05794392523364486,0.5859598144213128,1.0,4/11,11.24%,DAB2IP;TIRAP;TOLLIP;S100A8
prerank,SH3 domain binding (GO:0017124),0.5294835951303106,1.5196554202866226,0.01772525849335303,0.567672809860416,1.0,12/62,4.33%,SHANK3;DAB2IP;AFAP1L1;WASF2;ARHGAP27;ELMO1;AFAP1L2;ADAM15;PTPN12;CD2AP;EVL;GRB2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7389741319737826,1.5163910430715937,0.0550098231827112,0.5636970369564086,1.0,1/10,0.11%,MECOM
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.595392699242472,1.5106546935171268,0.05509181969949917,0.5702384296914427,1.0,13/30,19.75%,RPS6KA1;VIL1;XIAP;BIRC3;CST7;SPOCK1;PRDX5;PTTG1;CSTB;GAS6;SERPINB9;UBE2Z;RPS6KA3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7205125909025402,1.5066147107115908,0.05615942028985507,0.5703162255706957,1.0,6/12,12.37%,PIK3R6;PIK3R3;PIK3C3;PIK3C2A;IPMK;PIK3CB
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6507188270626161,-1.5050858681402397,0.06875,0.4514828200332347,1.0,4/12,4.45%,GAB2;IRS1;SHC1;FRS2
prerank,pre-mRNA binding (GO:0036002),-0.5353778084342867,-1.5043832542234354,0.035623409669211195,0.43599292314800114,1.0,10/28,22.09%,CELF2;DDX5;RNPC3;SRSF6;RBM41;U2AF2;TRA2B;U2AF1;TARBP2;RBM24
prerank,glutamate receptor binding (GO:0035254),0.6697607957501974,1.5025592163426251,0.04745166959578207,0.5705329043398073,1.0,4/17,6.43%,HIP1;SHANK3;HOMER2;HOMER1
prerank,GTPase activator activity (GO:0005096),0.43352975872299115,1.499109507416346,0.004524886877828055,0.5683686459728448,1.0,57/313,8.29%,CHN2;PLCB1;RASGRP3;DOCK4;DOCK9;FGD5;ARHGAP31;ARAP3;PREX2;TBC1D4;SRGAP2;RAPGEF2;RASGRF2;DENND3;RGS3;DOCK1;ARHGAP27;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;ARHGEF2;TBC1D14;TBC1D22A;KALRN;SIPA1L2;RAPGEF1;SIPA1;TIAM1;ABR;RIN3;TBC1D12;GNAQ;RALGAPA1;STARD13;DENND5B;RAPGEF3;TBC1D2;CYTH3;USP6NL;DENND4C;RAPGEF4;EPS8L2;CCDC88A;RAP1GDS1;OCRL;TBC1D5;SOS1;RASGRP2;ARHGAP25;RGL2;JUN;PREX1;ARHGEF5;OPHN1;IQGAP1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5486681155018929,1.4950822358304827,0.03582554517133956,0.5693855026424843,1.0,8/42,6.87%,BSG;ESAM;ROBO4;CD200;DSCAML1;STXBP6;BAIAP2;CNTN2
prerank,protein tyrosine kinase activity (GO:0004713),0.4811317352697402,1.495082217259385,0.014608233731739707,0.5544016736255768,1.0,21/108,7.06%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FES;FLT4;PTK2;JAK3;ZAP70;MERTK;LYN;CAMKK2;EPHA4;AATK;FYN;YES1;RET;HCK;EPHB4
prerank,protein tyrosine kinase binding (GO:1990782),0.49907748291188125,1.4807726497147835,0.030303030303030304,0.5952904912219262,1.0,20/71,17.44%,GRB14;DOCK4;BMPR2;TJP2;NEDD9;DUSP3;ELMO2;HYAL2;CD4;EPHA4;SHC3;SOCS5;ACP4;CEACAM1;CDH5;NCK1;ACVR1;CPNE3;GAS6;CBL
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6326327175125188,-1.4753371886685223,0.05647058823529412,0.5112566682646491,1.0,4/13,7.78%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,estrogen receptor binding (GO:0030331),0.5671021844765842,1.470820574566559,0.05329153605015674,0.6203395124536802,1.0,4/32,6.82%,LEF1;NCOA1;CTNNB1;TACC1
prerank,fibroblast growth factor binding (GO:0017134),-0.5555637797171438,-1.46580208498665,0.0665083135391924,0.5245825965877458,1.0,5/21,10.48%,FGFR2;THBS1;KL;API5;ITGAV
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.607945192206326,1.4620263113267662,0.048013245033112585,0.6410099102860382,1.0,5/24,7.01%,CERT1;DAB2IP;OSBP;SNX3;PLEKHA5
prerank,alkali metal ion binding (GO:0031420),-0.6168907352179827,-1.461362180395029,0.08423326133909287,0.521792973942323,1.0,3/13,8.59%,ATP1A2;HDAC4;TDG
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.5299402325176432,-1.4611884598209723,0.058823529411764705,0.5049635982920632,1.0,10/27,17.31%,ITPR1;SLC41A1;SLC12A2;CNNM2;SLC9B2;ITPR2;ZDHHC13;ATP2A3;MAGT1;ATP2B3
prerank,phosphatidylglycerol binding (GO:1901611),0.6810520840194539,1.4588427377453053,0.08785046728971962,0.63871898692985,1.0,3/13,5.26%,PLTP;PITPNC1;PITPNA
prerank,cyclic nucleotide binding (GO:0030551),0.6174164274139735,1.4570197384621095,0.0743362831858407,0.631214802418086,1.0,6/21,8.49%,PDE2A;RAPGEF2;CNGA2;PDE4D;RAPGEF4;PDE4B
prerank,solute:sodium symporter activity (GO:0015370),-0.5199150694782934,-1.4569548432768924,0.056265984654731455,0.5026659170064616,1.0,7/27,16.58%,SLC4A10;SLC5A6;SLC20A2;SLC4A7;SLC5A3;SLC5A7;SLC20A1
prerank,GTPase regulator activity (GO:0030695),0.43537866646802614,1.4537790917401872,0.014742014742014743,0.6302995310912851,1.0,36/212,8.29%,CHN2;PLCB1;RASGRP3;ARHGAP31;RGS12;ARAP3;PREX2;TBC1D4;SRGAP2;RAPGEF2;SH3BP4;RGS3;DOCK1;ARHGAP27;ARL2BP;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;ABR;TBC1D12;GNAQ;RALGAPA1;STARD13;TBC1D2;USP6NL;CCDC88A;RAP1GDS1;OCRL;TBC1D5;SOS1;ARHGAP25;JUN;PREX1;OPHN1;IQGAP1
prerank,phosphate ion binding (GO:0042301),0.7003480492793869,1.4525167417224907,0.09125475285171103,0.6209303438400989,1.0,3/10,11.16%,PDE2A;ADSS2;PNP
prerank,potassium ion leak channel activity (GO:0022841),-0.5901911109407073,-1.4515043715947666,0.0645933014354067,0.504273451530213,1.0,2/15,2.97%,KCNK2;KCNK5
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5091446948074679,1.450786573063683,0.03422619047619048,0.6137133796532447,1.0,12/60,7.06%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;ACVRL1;MERTK;EPHA4;RET;EPHB4
prerank,hexose transmembrane transporter activity (GO:0015149),0.6803202189375974,1.4480290870035875,0.103515625,0.6114144244410139,1.0,1/12,0.45%,SLC2A1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6829617953532815,1.4451017696453992,0.10131332082551595,0.6099010268035316,1.0,2/11,4.60%,LEF1;GATA2
prerank,poly(U) RNA binding (GO:0008266),-0.5577367124158983,-1.444965823090791,0.07962529274004684,0.5087076868674072,1.0,7/20,16.38%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5218380514943893,-1.4435786141114528,0.05343511450381679,0.4981930647174106,1.0,3/22,2.13%,RBMS3;CPEB1;CPEB2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5875958541307114,1.4413792034071897,0.07979626485568761,0.611745952977671,1.0,4/26,1.66%,SLC6A6;ABCG2;SLC16A4;SLC16A2
prerank,insulin-like growth factor I binding (GO:0031994),0.6605205587559391,1.4352336591177124,0.10142348754448399,0.6216638665802189,1.0,3/13,0.95%,IGF1R;ITGA6;INSR
prerank,chemorepellent activity (GO:0045499),0.5876720325562114,1.4351643839155734,0.0777027027027027,0.6096907767333092,1.0,7/25,9.35%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,peptidase inhibitor activity (GO:0030414),-0.48592680111830505,-1.4343794533200485,0.06299212598425197,0.5121830485884825,1.0,5/33,5.63%,TIMP2;TFPI;GPC3;ITIH2;SERPIND1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.4433404067221343,-1.430699501001344,0.042682926829268296,0.5097276143778674,1.0,14/55,12.73%,SLC24A3;ITPR1;MCU;ANXA2;PKD1;TRPC3;PKD2;ANXA6;CACNA1D;ITPR2;CACNB2;SLC24A5;PANX1;PSEN1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.406105263150681,-1.430614161507734,0.024734982332155476,0.49611251228276937,1.0,18/79,16.38%,CELF2;RBMS3;CPEB1;CPEB2;DDX5;RBMS1;CSDC2;AUH;YBX3;FXR2;RNF20;IGF2BP2;FMR1;PCBP4;HNRNPA2B1;TUT1;PABPC4;PABPC4L
prerank,glutamate receptor activity (GO:0008066),0.6066586780080795,1.428340873595287,0.10211267605633803,0.6227011229590464,1.0,12/19,24.59%,GRID2;GRIA4;GRIK5;GRIK2;GRIK1;GRM7;GRM8;GRIA2;GRM2;GRM3;GRIK3;GRID1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5152941817212382,1.4268251043130933,0.046199701937406856,0.6165932334136288,1.0,6/55,1.99%,SLC6A6;SLC7A5;SLC7A1;SLC16A4;SLC16A2;SLC38A5
prerank,metalloaminopeptidase activity (GO:0070006),-0.575978034609456,-1.4251410342630786,0.0851528384279476,0.49926178834494306,1.0,5/16,8.27%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5347302819473994,-1.4222614032165881,0.07090464547677261,0.49582158491448564,1.0,8/23,18.89%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L;U2AF2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6681665363041829,1.4187569652725505,0.11090909090909092,0.6352552180202521,1.0,5/12,11.97%,CNOT6L;NOCT;PAN3;PAN2;CNOT6
prerank,frizzled binding (GO:0005109),-0.47628038720192906,-1.4155317821144593,0.056179775280898875,0.5041428832239171,1.0,14/34,20.08%,WNT4;WNT5B;RNF43;WNT6;WNT9A;FZD7;MYOC;DVL2;WNT11;LRP6;RYK;SFRP1;WNT16;DVL3
prerank,glucose transmembrane transporter activity (GO:0005355),0.6094635103411883,1.415042009389035,0.12341197822141561,0.638262073463656,1.0,1/17,0.45%,SLC2A1
prerank,diacylglycerol kinase activity (GO:0004143),0.6828098891362213,1.4130425845163157,0.11619047619047619,0.6347655127606193,1.0,4/11,12.19%,DGKH;DGKI;DGKE;DGKZ
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6172693475267153,-1.4114483622524543,0.11258278145695365,0.5052644664914723,1.0,3/11,4.80%,KCNK2;KCNT2;PKD2
prerank,actin monomer binding (GO:0003785),0.5917069819794248,1.411119872460097,0.08880994671403197,0.6310044003493445,1.0,6/22,8.42%,NOS3;MRTFA;MTSS1;TMSB4X;TMSB10;TWF2
prerank,Hsp90 protein binding (GO:0051879),0.5512966510756291,1.4096998859349685,0.0782472613458529,0.6251069105371972,1.0,5/33,4.07%,KDR;UNC45B;NOD2;CYP2E1;FKBP6
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.5384639716419143,-1.4033364110549829,0.10723192019950124,0.5161622731613119,1.0,4/21,4.75%,FGF1;KL;FRS2;FGF2
prerank,fatty acid synthase activity (GO:0004312),0.7069760468787852,1.3957856210739792,0.13051823416506717,0.666241272774248,1.0,3/10,11.82%,ELOVL7;ELOVL5;ELOVL6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6802759266263623,1.3904056611365008,0.11172161172161173,0.6757550373949573,1.0,3/10,5.19%,SLCO1C1;SLCO2B1;SLC22A7
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.49544516244577624,-1.3861594688980616,0.10120481927710843,0.5565593345846466,1.0,13/25,25.03%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP6;PARP11;PARP1;SIRT2;TIPARP;SIRT6;ART3;TNKS
prerank,MHC class I protein binding (GO:0042288),0.6330045168123424,1.384995220567428,0.13926499032882012,0.6860424114760848,1.0,7/13,19.95%,PILRA;TUBB;TAP2;CD8B;ATP5F1A;TUBB4B;TAP1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.44879979358031397,1.383542667117808,0.055782312925170066,0.680284984427652,1.0,15/100,7.08%,CERT1;HIP1;ARAP3;MYO10;DAB2IP;ARAP2;HIP1R;PARD3;SNX13;OSBP;SNX3;CYTH3;TECPR1;PLEKHA5;PIRT
prerank,insulin-like growth factor binding (GO:0005520),0.622516172897751,1.3806177690071388,0.14035087719298245,0.6799179302361936,1.0,3/15,0.95%,IGF1R;ITGA6;INSR
prerank,poly-purine tract binding (GO:0070717),-0.48710287311786327,-1.3772297239917752,0.09725685785536159,0.5724431077242615,1.0,9/27,17.41%,RBMS3;RBMS1;DDX1;PATL1;FMR1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,actin binding (GO:0003779),0.4156771372657108,1.37439142938092,0.036991368680641186,0.692354403392285,1.0,37/170,10.94%,FLII;PARVB;UTRN;ABLIM1;SYNE1;MACF1;MYRIP;NOS3;KLHL2;SLC6A2;MRTFA;FLNB;PTK2;CORO2B;MTSS1;NOD2;VASH1;SSH2;MYO6;TMSB4X;EPS8;EPS8L2;CCDC88A;ACTN4;DBNL;FHL3;PRICKLE4;PARVG;MSRB2;SORBS1;TMSB10;TWF2;TMOD1;PHACTR4;MYO1F;MOBP;FERMT2
prerank,clathrin adaptor activity (GO:0035615),0.6258857202257705,1.374191765750768,0.12797074954296161,0.682351082423017,1.0,4/15,12.58%,HIP1;HIP1R;AP2M1;AP2B1
prerank,ATPase binding (GO:0051117),-0.4007422388567438,-1.372742630641578,0.04513888888888889,0.5746221351197618,1.0,21/71,14.63%,ANK2;EGFR;SLC2A13;PTPN3;SNTA1;ABCA1;PKD2;AR;ATP6V0A4;ATP1B3;TMTC4;ATP1B2;SELENOS;EZR;TOR1AIP1;ESR1;PGR;PSEN1;SYVN1;ATP5IF1;NKD2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.44965746396561895,-1.36899210176146,0.05774278215223097,0.5747816885688172,1.0,11/37,14.04%,CACNA1C;CACNA2D3;CACNA2D1;PKD2;CACNA1G;CACNA1D;CACNB4;ITGAV;CACNB2;CATSPER3;CACNB1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6141675826701557,1.3662871235214575,0.14414414414414414,0.701533730321774,1.0,4/15,9.37%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,histone demethylase activity (GO:0032452),-0.47968145032956133,-1.3651970789436276,0.10512820512820513,0.5741513072477283,1.0,13/27,23.33%,KDM7A;KDM2A;KDM3B;KDM5B;FBXL19;KDM6B;KDM2B;PHF8;KDM1A;RIOX2;PHF2;KDM4D;HR
prerank,MAP kinase phosphatase activity (GO:0033549),0.6324912144948034,1.3638875777410553,0.14312267657992564,0.6997932727431592,1.0,5/12,14.77%,DUSP7;DUSP3;DUSP1;DUSP16;DUSP8
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.47053854826554004,-1.36236331799683,0.0979381443298969,0.5706456738973301,1.0,8/31,13.19%,KCNK5;SLC12A2;PKD2;ABCC9;KCNQ4;SLC12A7;TMEM175;SLC12A4
prerank,protein kinase C activity (GO:0004697),0.6267659240526302,1.3580154706949967,0.15232974910394265,0.7115600095875703,1.0,4/14,5.51%,PRKCH;PRKD1;PRKD3;PKN1
prerank,double-stranded RNA binding (GO:0003725),0.45881597037200317,1.3554856817019698,0.08563134978229318,0.7099718811649485,1.0,19/70,16.07%,TFRC;LRRFIP1;IFIH1;ADAR;HSP90AB1;TLR3;EIF4H;ACTN1;TLR7;MSN;SLC3A2;OASL;TLR8;RFTN1;ADAD1;ELAVL1;TUBB4B;EIF4A1;MRPL44
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5838951218899526,1.3500493281984258,0.14495412844036698,0.7208843630778009,1.0,9/18,22.23%,RPS6KA1;VIL1;XIAP;BIRC3;PRDX5;GAS6;SERPINB9;RPS6KA3;SNCA
prerank,alpha-actinin binding (GO:0051393),-0.4959503684638643,-1.349739199015683,0.1002710027100271,0.5969851967553641,1.0,8/24,7.90%,CACNA1C;PALLD;PDLIM7;DAG1;PKD2;PDLIM2;CACNA1D;PDLIM4
prerank,poly(A) binding (GO:0008143),-0.5030101259291949,-1.3491612577186822,0.13729977116704806,0.5870351051066715,1.0,7/21,17.41%,RBMS3;RBMS1;DDX1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,ribosomal large subunit binding (GO:0043023),-0.5895549186719914,-1.3489494584101216,0.13260869565217392,0.5760512749254937,1.0,1/11,2.13%,CPEB2
prerank,metalloexopeptidase activity (GO:0008235),-0.4165478381537618,-1.3430079143483638,0.07428571428571429,0.5826120439468726,1.0,14/51,15.57%,CPQ;AEBP1;MMP14;MMP16;ANPEP;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;AGBL1;PEPD;ACE2;ZMPSTE24
prerank,amino acid transmembrane transporter activity (GO:0015171),0.49761961973595914,1.3418202260777923,0.10599078341013825,0.7415365679069901,1.0,6/47,2.92%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5;SLC43A2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.46862908135054804,1.341285495610934,0.0771513353115727,0.7329514173169966,1.0,11/60,7.06%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;MERTK;EPHA4;RET;EPHB4
prerank,active ion transmembrane transporter activity (GO:0022853),0.5043671465072247,1.3373559671461608,0.1185064935064935,0.7379054903887614,1.0,4/37,5.19%,SLCO1C1;SLCO2B1;SLC22A8;SLC22A7
prerank,carboxylic ester hydrolase activity (GO:0052689),0.44976731414178567,1.3361699933235796,0.08123249299719888,0.7325842190751823,1.0,11/85,10.48%,ABHD2;BCHE;LIPE;PLA2G4B;PNPLA6;NOTUM;GDPD1;LIPC;ENPP2;LYPLA1;PTRH2
prerank,death domain binding (GO:0070513),0.6366766035970538,1.3361131163937219,0.15769944341372913,0.7229903345748365,1.0,4/11,8.01%,BCL2L1;CRADD;MCL1;IRGM
prerank,transcription coactivator binding (GO:0001223),-0.5127022389977981,-1.333371397366258,0.1141552511415525,0.6012758488963212,1.0,9/20,11.97%,SMAD3;THRB;CCNT2;AR;RORA;MED25;VGLL4;ESR1;PGR
prerank,motor activity (GO:0003774),0.4677664085392946,1.3327803442358945,0.09351432880844646,0.7252000556945289,1.0,12/60,12.72%,MYO1E;STARD9;KIFC3;MYO6;DNAH3;KIF26A;KIF2A;KIF1A;PIN1;KIF3B;KIF23;DNAH8
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6154772035186861,-1.3307603926575262,0.12931034482758622,0.5980074484195292,1.0,4/10,9.26%,ANO6;CLCN2;ANO1;CLCN6
prerank,lipase activator activity (GO:0060229),-0.5899449338638477,-1.3306900009278406,0.14533622559652928,0.5873878091028996,1.0,2/10,9.08%,ARHGAP6;PDPK1
prerank,MHC protein binding (GO:0042287),0.5587985784591121,1.3295692717703465,0.15760869565217392,0.7276390381978093,1.0,8/20,15.24%,PILRA;CD4;TUBB;TAP2;CD8B;KIR3DL2;ATP5F1A;TUBB4B
prerank,endopeptidase activity (GO:0004175),-0.32513230578711516,-1.3286322920371438,0.005813953488372093,0.5832051014553231,1.0,63/257,19.29%,TRABD2B;THSD4;ADAMTS2;ADAMTSL3;ADAMTS12;ADAMTS10;ADAMTS6;ADAMTSL5;PCSK5;HTRA3;MMP14;MMP16;F3;USP11;USP24;ADAMTS17;ADAMTS5;ADAM9;ADAMTSL4;BACE2;FAP;CTSL;ADAMTS15;ADAMTSL1;USP40;MMP2;ADAMTS16;ACE;DPP4;ADAM19;KLK2;USP2;ADAM33;IDE;RHBDL3;MMP19;AFG3L2;ADAMTS1;PSEN1;CTSH;HTRA2;HTRA4;USP42;CASP3;CTSZ;USP9X;ADAMTS14;ACE2;ZMPSTE24;NRDC;MASP1;ADAMTS9;PRSS12;CASP6;RHBDF1;PARL;MBTPS1;SFRP1;USP16;GZMM;PCSK6;TASP1;USP13
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5535024696951347,1.3265146375031693,0.15265866209262435,0.7298482662580664,1.0,9/22,17.23%,DUSP23;DUSP7;DUSP3;DUSP12;DUSP1;DUSP16;DUSP8;MTMR2;PPM1F
prerank,adenylyltransferase activity (GO:0070566),0.5549407100301589,1.3244400083763732,0.14261168384879724,0.7280137701352375,1.0,5/21,9.61%,TENT4A;MTPAP;FICD;GPHN;OASL
prerank,nucleoside-diphosphatase activity (GO:0017110),0.622046832528747,1.323348582951469,0.18197879858657243,0.7225881790604014,1.0,2/12,6.18%,ENTPD1;ENTPD5
prerank,ephrin receptor activity (GO:0005003),-0.5170922910111743,-1.3227697085191554,0.14823008849557523,0.5797490076991803,1.0,4/17,7.27%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5170922910111743,-1.3227697085191554,0.14823008849557523,0.5797490076991803,1.0,4/17,7.27%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,sterol transfer activity (GO:0120015),0.5812775829120946,1.322000755443186,0.15834767641996558,0.7184732614092347,1.0,3/17,3.88%,PLTP;OSBP;ABCG1
prerank,mannosyltransferase activity (GO:0000030),0.5630743727248442,1.3216038582430156,0.15859766277128548,0.7109961039649108,1.0,1/21,0.08%,TMTC2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5854636937713714,-1.3209751980898066,0.1522198731501057,0.5749642285317196,1.0,4/10,22.79%,DSE;RENBP;GALE;FUOM
prerank,manganese ion binding (GO:0030145),-0.4112191204356954,-1.3140908759550576,0.1111111111111111,0.5856589566085679,1.0,16/48,22.85%,MPPED2;LARGE1;ME1;ADCY2;TDP2;SOD2;B4GALT1;FAM20C;ABL1;DYRK2;PPM1M;PRIMPOL;WRN;XPNPEP3;ATP13A2;GALNT1
prerank,cGMP binding (GO:0030553),0.6291285759394364,1.3127085501188716,0.20224719101123595,0.7337859884757507,1.0,3/11,3.83%,PDE2A;RAPGEF2;CNGA2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.565854501846354,1.3117577398325189,0.17192982456140352,0.7280842247974755,1.0,4/18,9.37%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6049184189786644,1.3098176655365061,0.19136960600375236,0.7261993162314168,1.0,4/13,2.58%,PDGFB;PDGFD;IL1R1;PTPRJ
prerank,muscle alpha-actinin binding (GO:0051371),-0.5353866549940427,-1.3091051431181016,0.14425427872860636,0.5904419084397211,1.0,5/15,7.90%,PALLD;PDLIM7;PKD2;PDLIM2;PDLIM4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6091141475510716,1.308652949111776,0.17261904761904762,0.7215000084195197,1.0,2/12,5.07%,TENT4A;MTPAP
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.5692257478620273,-1.304037433905187,0.1837160751565762,0.5953593861888647,1.0,5/11,12.18%,AMFR;UBR5;UBE4B;PPIL2;PRPF19
prerank,CARD domain binding (GO:0050700),0.6071436986273833,1.3039435699741098,0.20454545454545456,0.7285562199425882,1.0,6/14,15.51%,NOD1;NOD2;CARD10;IRGM;BCL10;CARD11
prerank,kinase inhibitor activity (GO:0019210),-0.4399366323584443,-1.3037084521041415,0.14133333333333334,0.5866513941657201,1.0,15/33,28.91%,PARVA;GMFB;QARS1;DUS2;LRP6;CDKN1C;DNAJC3;MAPK8IP1;SMCR8;RHOH;SOCS3;TAOK3;DUSP19;AHSG;TRIB1
prerank,phospholipase binding (GO:0043274),-0.5541612999580023,-1.3028757815699232,0.14508928571428573,0.5799098061059487,1.0,3/13,9.08%,ARHGAP6;PRKN;PDPK1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.47758972561261825,-1.3009363830382747,0.15625,0.5758244051082191,1.0,10/24,20.78%,CAMK1D;CAMK2D;MAPKAPK3;PHKA2;PTK2B;EEF2K;CAMK1;PHKG2;CAMKK1;PHKA1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.48702214906433533,1.300713092932548,0.15716486902927582,0.7309486205289861,1.0,7/38,7.01%,HIP1;DAB2IP;PARD3;SNX13;SNX3;TECPR1;PLEKHA5
prerank,symporter activity (GO:0015293),0.6374998737227607,1.299638060988103,0.19366852886405958,0.7262867152749976,1.0,1/10,0.47%,MFSD2A
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5282929603907405,-1.294129091905296,0.15217391304347827,0.5862724203968792,1.0,3/14,2.05%,FHIT;ENPP1;NUDT4
prerank,protein phosphatase binding (GO:0019903),0.411445367661666,1.2940327009026316,0.102803738317757,0.7371680582964852,1.0,15/117,5.26%,MFHAS1;PPP1R16B;DAB2IP;ITGA1;FLT4;CTTNBP2NL;PTK2;FOXO1;JAK3;PXN;PPP1R9B;SNX3;CTNNB1;STRN4;KCNQ1
prerank,phosphatidic acid binding (GO:0070300),0.5569839987377728,1.2922133597214016,0.1602112676056338,0.7353847838838586,1.0,3/19,5.18%,PLTP;RAPGEF2;PITPNC1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.622904013734648,1.2865470357138962,0.2103386809269162,0.7468249283071559,1.0,5/12,13.96%,DAB2IP;CCDC88A;GREM1;PGF;CDH5
prerank,transcription corepressor binding (GO:0001222),-0.46526053581834853,-1.285870016379495,0.15180722891566265,0.6019764994635309,1.0,8/27,11.46%,PER3;USP11;NEK6;EHMT2;PER2;RORA;LCOR;ESR1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5233466432250423,1.2855229044618752,0.15609756097560976,0.7423114918448404,1.0,7/27,12.70%,RNF144B;DCUN1D3;FOXL2;RNF125;TOLLIP;UBE3D;DCUN1D1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4560750371208806,1.28327705665807,0.13663663663663664,0.741853913322615,1.0,14/52,12.79%,ETS1;NCOA1;PKN1;ACTN4;TACC1;ACTN1;BUD31;NCOA2;HMGA1;CNOT9;HELZ2;PRKCB;CNOT6;PSMC3IP
prerank,vinculin binding (GO:0017166),0.6102137978896404,1.2812147107877752,0.2115732368896926,0.7409835265247685,1.0,5/11,9.53%,UTRN;CORO2B;PXN;ACTN1;SYNM
prerank,protein phosphorylated amino acid binding (GO:0045309),0.47281087157379986,1.2811930341270388,0.15723270440251572,0.7333276542847633,1.0,14/42,12.14%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;FBXW7;YES1;HCK;PIN1;SHC3;PTPN5;SHB;SHF;SYK
prerank,cardiolipin binding (GO:1901612),-0.5987209905690077,-1.2782715816821788,0.19574468085106383,0.6150827865442771,1.0,3/10,19.11%,GSDME;GSDMD;PLEKHN1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5217038757131924,1.2768118750780453,0.19932998324958123,0.7403929794274514,1.0,5/23,10.96%,HIP1;HIP1R;SNX3;PLEKHA5;CLVS2
prerank,store-operated calcium channel activity (GO:0015279),-0.5792630671445249,-1.2755146659318608,0.20484581497797358,0.6137233029572682,1.0,4/10,13.02%,TRPC3;TRPC6;TRPC4;ORAI2
prerank,MHC class II protein complex binding (GO:0023026),0.6114215022234094,1.273760209941614,0.21164021164021163,0.7430347386821536,1.0,4/11,10.78%,HSP90AB1;CD4;PKM;HSPA8
prerank,"DNA binding, bending (GO:0008301)",0.5860461447462334,1.2728331412771425,0.19464285714285715,0.7388736658836941,1.0,2/14,4.43%,LEF1;HHEX
prerank,myosin II binding (GO:0045159),0.6224124267660337,1.2720773663662313,0.22113502935420742,0.7338025489462998,1.0,2/10,1.45%,SHROOM4;SHROOM1
prerank,CXCR chemokine receptor binding (GO:0045236),0.6008957987375414,1.2651820789636086,0.2255083179297597,0.7490269592213856,1.0,1/11,1.28%,CXCL12
prerank,sulfotransferase activity (GO:0008146),-0.431243763902309,-1.2615495590325492,0.15938303341902313,0.6444922656350632,1.0,9/33,15.43%,UST;HS3ST3A1;HS2ST1;CHST15;HS6ST1;CHST8;CHST3;GAL3ST2;CHST1
prerank,hexosyltransferase activity (GO:0016758),0.40889119613417557,1.260579957108401,0.13991769547325103,0.7569986154071289,1.0,10/101,7.35%,TMTC2;CSGALNACT1;GBE1;B4GALT5;B4GALT4;MFNG;B3GNT2;FUT9;PIGM;GCNT7
prerank,5'-3' exonuclease activity (GO:0008409),0.5654094163445841,1.2533058649291329,0.20255474452554745,0.7740205031113238,1.0,9/14,21.02%,MRE11;DCP2;DXO;FAN1;TRIR;EXOG;XRN1;XRN2;DCLRE1C
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.36362833867995376,1.250802170600435,0.07981220657276995,0.77494203548022,1.0,31/254,8.28%,LEF1;MECOM;ETS1;ERG;ELK3;ZIC3;SOX17;KLF7;MEF2C;FOXO1;PRDM2;ZBTB16;IRF2;FOXF1;HHEX;RREB1;CREB1;NKX2-8;KLF4;NR1H2;GTF2I;IRF5;SOX18;NFIC;HINFP;SOX12;JUN;TCF12;KLF6;ATF6B;ELK4
prerank,phospholipase activator activity (GO:0016004),-0.5597479842535562,-1.2472337189951377,0.21108742004264391,0.6793264936234694,1.0,2/10,9.08%,ARHGAP6;PDPK1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.399351521908597,1.245784982768638,0.14789687924016282,0.7838055169252549,1.0,18/91,10.96%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;SNX3;KCNQ1;SYT7;PLEKHA5;PIRT;FCHO2;TWF2;CAPG;AMER2;CLVS2
prerank,epidermal growth factor receptor binding (GO:0005154),0.502288169173282,1.2442855904735766,0.19900497512437812,0.7819955230167106,1.0,6/25,12.34%,HIP1;GRB2;CCDC88A;TGFA;CNOT9;TNK2
prerank,GTPase binding (GO:0051020),0.373575439251805,1.243393933517971,0.09359605911330049,0.7775095169398631,1.0,36/194,13.32%,DOCK4;FGD5;SPTBN1;SRGAP2;RASIP1;SH3BP4;CAV1;FNBP1L;UNC13B;ARHGEF2;RIN3;YBX1;PEX5L;EPS8;USP6NL;PKN1;RAPGEF4;OCRL;UNC13D;NCKAP1;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;CYFIP1;BICDL1;KIF3B;EXOC4;EXOC2;TBC1D30;GNB1;RANBP9;CYRIB;TMEM127;FGD2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4468723777971884,1.242121893103935,0.18777943368107303,0.7744350266888991,1.0,6/53,5.09%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC43A2;SLC1A2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4234383236631852,-1.2408467973013535,0.15544041450777202,0.688350584091547,1.0,13/33,25.10%,AR;CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4;TBP;WAC;UVSSA;SMYD2
prerank,protein homodimerization activity (GO:0042803),0.34617806638144166,1.2405265781138373,0.047058823529411764,0.7726503620371754,1.0,101/589,12.51%,TFRC;ABCG2;HIP1;PECAM1;PDGFB;SRGAP2;CADM1;BCL2L1;DAB2IP;SYNE1;RASIP1;TGFB2;PDE2A;ZHX3;XDH;TBX1;TPD52;IL6R;FLT4;HIP1R;GCH1;TPD52L1;TRIM14;B2M;F11R;FZD4;NOD1;LRRFIP1;TBC1D22A;KLHL7;DEFA6;GBP4;STK10;DSCAML1;GBP5;ABCG1;VIL1;ZBTB16;IKBKB;SARS1;HHEX;NOS2;MTPAP;HSP90AB1;CD4;ACOX1;GSTA4;CAT;CCDC88A;INPP5F;ACTN4;TPST2;STAT1;ADAM10;TOX3;MCL1;ACTN1;YARS2;FICD;BST2;ST6GAL1;ACSL6;MKLN1;KCNH2;SHMT2;TERF2;KCNN2;CST7;FOXP3;RAB11FIP4;IRAK2;CPOX;PDXK;PRDM9;GLB1;CAV2;GREM1;BNIP3L;SNRPC;HPGDS;CBS;BANF1;CNOT9;COQ9;PDCD10;MID1;TIMM10;TPM4;HOOK1;ABCD1;HSPB1;PIP4K2A;RBPMS;SLK;SH3GLB1;MMAA;CEACAM1;TERF1;NAA60;PANK3;GDF15
prerank,R-SMAD binding (GO:0070412),-0.48057040461638145,-1.2386410007515836,0.2099056603773585,0.685544080002605,1.0,4/18,2.35%,LDLRAD4;SMAD3;DDX5;SMAD6
prerank,disordered domain specific binding (GO:0097718),0.517184209459051,1.2374837661261393,0.2281303602058319,0.7757960670867728,1.0,4/23,8.78%,CALM1;HSP90AB1;FYN;DFFB
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3641365459517484,1.2350733991892666,0.0936768149882904,0.7762096298842109,1.0,41/248,12.80%,DNM3;MYO1E;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MYO6;MTG1;KIF26A;GNA12;EFTUD2;RHOB;TBC1D24;ABCA3;ATP2B1;KIF2A;KIF1A;RALB;RAB11A;RAP1B;DNM2;IRGM;PIN1;DNA2;GTPBP1;GPN3;RAB3B;GFM1;RAC1;ABCD1;HRAS;RAB4A;MMAA;GPN2;RND1;GNB1;RAB1A
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.41574391522625176,1.2338875186367164,0.17048710601719197,0.7731938428296266,1.0,13/72,9.11%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;KCNQ1;SYT7;FCHO2;TWF2;CAPG
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.511549562395134,1.232776699482067,0.2328042328042328,0.7700005850760214,1.0,6/23,11.27%,PLCB1;PLCB4;PLCG1;PLCH2;PLCH1;CHRM3
prerank,cytokine activity (GO:0005125),-0.32419508855546936,-1.2302004823048978,0.07818930041152264,0.7030994067012011,1.0,14/131,4.75%,BMP6;IL34;WNT4;BMP5;BMP7;BMP4;WNT5B;WNT6;IL18;TNFRSF11B;CXCL16;WNT9A;IL16;FGF2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.45773612899536364,-1.2287935636231544,0.17206982543640897,0.6981018949752974,1.0,6/20,15.27%,MOGAT3;AGPAT4;LPGAT1;LCLAT1;GPAT3;PNPLA3
prerank,protein kinase binding (GO:0019901),0.3447776899760361,1.2285379456876908,0.05285868392664509,0.7769139369248665,1.0,102/479,14.82%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;BMPR2;MAP4K2;CAV1;TJP2;TIRAP;GCH1;TRIM14;NEDD9;STK38;PTPRJ;TBC1D14;PTK2;RGCC;IFNAR2;DUSP7;ACVRL1;NOD2;MAP3K1;PRKD2;HDAC9;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;GRB2;CALM1;HINT1;CEP68;CD4;KCNQ1;RHOB;PKN1;EPHA4;CCDC88A;CDKN2B;TSKS;RFFL;ADAM10;ADCY4;IRF5;SPAG9;PTPRR;PRKAR2B;PTN;LRBA;IRGM;PIN1;IQGAP1;FAM83G;ACSL3;TWF2;MSN;RPS7;ARHGEF7;SHC3;CDK5RAP2;CAV2;PPP1CB;CCND3;CAVIN2;PDCD10;DCX;TRIB2;SMAD1;PRKAR2A;PRKAB1;GRB7;RAC1;NBEAL2;FERMT2;DUSP1;HSPB1;EXOC2;GSK3A;HIF1A;PRKCB;RPTOR;ADIPOR1;RND1;CEACAM1;CCNK;MAPRE3;DUSP16;CYLD;SOX9;PGAM1;CDH5;BCL10;PDE3B;HDAC5;NR3C1;NELL2;VRK1;DUSP8;ELAVL1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5565135245188318,-1.2271346036403459,0.24036281179138322,0.6941259864229454,1.0,5/10,11.87%,SLC24A3;SLC8A3;SLC8B1;SLC8A1;SLC24A5
prerank,transmitter-gated ion channel activity (GO:0022824),0.48472018815601614,1.2261024877179452,0.21947194719471946,0.7781060331866313,1.0,17/29,26.19%,GRID2;CHRNB1;GABRB1;GRIA4;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GRIA2;GRIK3;GRID1;GABRA2;GABRG2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5091035755878554,1.2255775450975526,0.19738988580750408,0.7730242581865199,1.0,4/25,6.30%,HIP1;ARAP3;HIP1R;PLEKHA1
prerank,cytokine receptor binding (GO:0005126),0.40608154245272904,1.2251926066410312,0.1631504922644163,0.7676606174687128,1.0,16/83,13.14%,KITLG;CXCL12;TGFB2;IL6R;PXDN;SOCS2;OSMR;LIFR;TNFSF11;PGF;ADAM17;CNTF;SYK;DDT;IL27RA;SDCBP
prerank,PDZ domain binding (GO:0030165),0.42908576721681374,1.2240694243019226,0.1690340909090909,0.7646750665784222,1.0,15/61,10.02%,DOCK4;USHBP1;CADM1;RAPGEF2;F11R;FZD4;ACOX1;ATP2B1;GRID2;PLEKHA1;SLC9A3;TMEM88;TMEM88B;CLCN3;ADAM17
prerank,LRR domain binding (GO:0030275),-0.5151848614336118,-1.2227665210320493,0.2325056433408578,0.6980826017652475,1.0,2/14,0.50%,ROBO1;PAWR
prerank,protein phosphatase 1 binding (GO:0008157),0.5163926596012991,1.222495177917986,0.22847100175746923,0.7628778888828924,1.0,5/21,9.48%,PPP1R16B;PPP1R9B;KCNQ1;PPP1R11;PHACTR4
prerank,growth factor receptor binding (GO:0070851),0.4023843882914804,1.221333720777521,0.15804195804195803,0.7600404789961966,1.0,18/95,13.14%,HIP1;PDGFB;PDGFD;IL1R1;IL6R;PTPRJ;GRB2;FGF16;CCDC88A;FYN;TGFA;PGF;CNOT9;ADAM17;CNTF;TNK2;IL27RA;SDCBP
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.4821278041911694,1.2193888390401648,0.21324717285945072,0.7597872359315749,1.0,7/33,12.70%,RNF144B;DCUN1D3;FOXL2;RNF125;TOLLIP;UBE3D;DCUN1D1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5040101377920361,-1.218492828840185,0.2408256880733945,0.7016954408587605,1.0,2/14,2.76%,SLC26A7;SLC26A2
prerank,phosphotyrosine residue binding (GO:0001784),0.4642688844930066,1.2176528324891742,0.21568627450980393,0.7591351802085469,1.0,12/37,12.14%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;YES1;HCK;SHC3;PTPN5;SHB;SHF;SYK
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4732257282423723,1.210656969536146,0.22843450479233227,0.7745220336118875,1.0,6/34,4.73%,ARAP3;MYO10;ARAP2;HIP1R;PARD3;CYTH3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5801879308768535,1.2098779829610753,0.287593984962406,0.7645456240564497,1.0,5/10,20.47%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5801879308768535,1.2098779829610753,0.287593984962406,0.7645456240564497,1.0,5/10,20.47%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.43269248396605275,-1.2086111969649864,0.18227848101265823,0.7230603638350307,1.0,8/27,11.35%,SLC41A1;SLC8A3;SLC9A2;SLC8B1;SLC9B2;SLC8A1;SLC9A9;SLC9A1
prerank,nuclear export signal receptor activity (GO:0005049),-0.5287666902482401,-1.2064586260005559,0.2543103448275862,0.720252082758929,1.0,4/11,16.72%,RANBP17;XPO5;XPO6;XPO1
prerank,kinase binding (GO:0019900),0.3398004215300732,1.2017314734089017,0.08158765159867695,0.7843087587530402,1.0,81/434,12.53%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;CAV1;FAS;PDE8A;BCAR3;TRIM14;PTPRJ;TBC1D14;PTK2;RGCC;STX1A;SP100;IFNAR2;ACVRL1;NOD2;TIAM1;MAP3K1;PIK3IP1;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;GRB2;CALM1;CTNNB1;CEP68;HSP90AB1;CD4;RHOB;CDKN2B;TTC28;TSKS;ATP1A4;PPP2R5A;RFFL;ADAM10;IRF5;PTPRR;CD160;PTN;LRBA;IRGM;IQGAP1;FAM83G;ACSL3;MSN;RPS7;ARHGEF7;SHC3;CDK5RAP2;CAV2;PPP1CB;CCND3;CNOT9;BTG1;PDCD10;DCX;SMAD1;PRKAB1;GRB7;CDC6;UBQLN1;TOLLIP;RAC1;NBEAL2;FERMT2;HSPB1;EXOC2;HIF1A;RPTOR;ADIPOR1;RND1;CEACAM1;CCNK;MAPRE3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5959178112870279,1.2012191363680178,0.26678765880217786,0.7798157968549174,1.0,3/10,13.57%,SHANK3;SHISA6;IGSF11
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2671473081273789,-1.2010829656962343,0.0,0.7272769800285318,1.0,136/731,14.03%,FOXP2;PBX1;SOX5;MAF;NFIA;ZIC1;ZIC4;NR2F2;ZEB2;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;CREB5;ZFHX3;GLI2;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;FOXP4;PKNOX2;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;MEOX2;NFAT5;THRB;HDAC4;TOP1;IKZF2;MXI1;HOXB4;PRRX2;TEF;CREB3L2;SALL1;HOXB6;NR1D2;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;PLAGL1;MLXIP;HOXA7;ZNF423;RBPJ;MKX;ZNF367;AR;GLIS2;PBX4;PPARA;HIF3A;KLF3;SIX1;NR3C2;EBF4;RUNX2;IKZF4;RORA;TBX18;TEAD3;HEYL;BCL6;CHD2;GLI1;PBX3;SMAD9;MEIS1;ZFAT;ZNF568;FOXJ2;EBF2;NFATC4;ZSCAN29;KLF15;ZEB1;ELF4;RFX7;FOXL1;KDM6B;MITF;POU6F1;ATOH8;HSF2;ZNF23;SOX6;STAT5A;MGA;FOXO3;ZKSCAN7;ZNF483;CEBPB;CREB3L1;ELK1;ZNF697;ARNT;ZNF148;ZNF182;NR2F1;ETV1;GATA6;ZBTB38;ESR1;RXRA;PRMT5;TFCP2L1;PGR;ZNF219;SKI;HOXB5;HOXC5;ZBTB4;E4F1;FOXE1;TWIST1;NKX6-1;SP3;SNAI1;HOXA9;GZF1;MTF1;NR4A1;ZBTB1
prerank,cholesterol transfer activity (GO:0120020),0.5341063353939579,1.199856856255715,0.25996533795493937,0.7777601950753185,1.0,2/16,3.88%,PLTP;ABCG1
prerank,calcium-release channel activity (GO:0015278),-0.4640306561043317,-1.1995894361407309,0.19103773584905662,0.7227509266046259,1.0,5/17,13.62%,ITPR1;PKD2;RASA3;ITPR2;TPCN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5720371203359148,1.1993661803149576,0.2718631178707224,0.7731465528010091,1.0,1/11,1.88%,DDAH1
prerank,FMN binding (GO:0010181),0.5729857110321424,1.1993602450836662,0.27655310621242485,0.7672069893070068,1.0,2/11,4.55%,NOS3;NOS2
prerank,adenylate cyclase binding (GO:0008179),-0.5417610951089878,-1.198803086061542,0.2803532008830022,0.7162124806445767,1.0,3/10,4.25%,ADCY5;AKAP12;ADCY2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40790603141640264,1.198626605980927,0.1968390804597701,0.7637170066515314,1.0,8/71,5.02%,PTPRG;PTPRM;PTPRB;PTPRJ;DUSP23;PTPN12;DUSP3;CDC14A
prerank,water transmembrane transporter activity (GO:0005372),0.5843237191293456,1.1973276423923176,0.28735632183908044,0.7618760593540886,1.0,2/11,4.61%,AQP11;AQP7
prerank,hormone receptor binding (GO:0051427),0.5441685696249823,1.1963995702746484,0.2703180212014134,0.758946342918673,1.0,2/14,4.91%,SOCS2;NPPA
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.531792053798451,-1.1940386788159068,0.26939655172413796,0.7216963281061212,1.0,5/10,16.33%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4886678448995938,1.1922787037739417,0.2602739726027397,0.7660259536757749,1.0,6/24,9.99%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,alpha-tubulin binding (GO:0043014),0.46318993370395206,1.1922114437700717,0.24671052631578946,0.7605226197030384,1.0,5/31,8.47%,TTLL7;EFHC2;DIP2B;FYN;TRIM36
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.26397497072998743,-1.1904143411299908,0.0,0.7238677642044247,1.0,115/732,11.50%,FOXP2;PBX1;SOX5;MAF;NFIA;ZIC1;ZIC4;NR2F2;ZEB2;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;CREB5;ZFHX3;GLI2;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;FOXP4;PKNOX2;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;MEOX2;NFAT5;THRB;HDAC4;TOP1;IKZF2;MXI1;HOXB4;PRRX2;TEF;SALL1;HOXB6;NR1D2;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;PLAGL1;MLXIP;HOXA7;ZNF423;RBPJ;MKX;ZNF367;AR;GLIS2;PBX4;PPARA;HIF3A;KLF3;SIX1;NR3C2;EBF4;RUNX2;IKZF4;RORA;TBX18;TEAD3;HEYL;BCL6;CHD2;GLI1;PBX3;SMAD9;MEIS1;ZFAT;ZNF568;FOXJ2;EBF2;NFATC4;ZSCAN29;KLF15;ZEB1;ELF4;RFX7;FOXL1;KDM6B;MITF;POU6F1;ATOH8;HSF2;ZNF23;SOX6;STAT5A;MGA;FOXO3;ZKSCAN7;ZNF483;CEBPB;ELK1;ZNF697;ARNT;ZNF148;ZNF182;NR2F1;ETV1;GATA6;ZBTB38;ESR1;RXRA
prerank,CoA-ligase activity (GO:0016405),-0.5005751939765164,-1.1903303631414734,0.2562929061784897,0.715693614957947,1.0,4/14,15.25%,ACSL1;ACSS3;AACS;ACSS1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5780396388041462,1.1886659059136864,0.30401529636711283,0.7652881240237396,1.0,6/10,23.05%,ATXN3;TNFAIP3;CYLD;OTUD4;DESI2;STAMBP
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3764807799607837,-1.1866314583818482,0.20334261838440112,0.7181585589687626,1.0,6/46,4.31%,B3GALT1;LARGE1;MGAT3;EXT1;MGAT4C;OGT
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4472462658986367,-1.1865680782922825,0.22935779816513763,0.7101559308669007,1.0,4/21,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,pseudouridine synthase activity (GO:0009982),-0.5147527346530669,-1.1863431879451807,0.24444444444444444,0.7027802409889938,1.0,6/13,30.20%,PUS7;PUS10;RPUSD4;RPUSD1;RPUSD2;RPUSD3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4394227169055992,-1.1861355052927998,0.23557692307692307,0.6955242417242313,1.0,4/23,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,TBP-class protein binding (GO:0017025),0.484700076261782,1.1821237535231996,0.2602739726027397,0.7793652668353132,1.0,6/21,20.19%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5493468900863789,1.180438182394032,0.2902621722846442,0.7788795909329189,1.0,5/12,8.49%,PDE2A;PDE8A;PDE4D;PDE7B;PDE4B
prerank,acid-thiol ligase activity (GO:0016878),-0.5002852813439418,-1.1791285672180076,0.2857142857142857,0.7082035865428936,1.0,6/13,25.91%,ACSL1;ACSS3;AACS;ACSS1;ACSS2;AASDH
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.573525949708953,1.1762112344575726,0.27807486631016043,0.7857993279588243,1.0,2/13,1.99%,SLC7A1;SLC38A5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.534728046912416,-1.1729897176774657,0.28781512605042014,0.7182500353957242,1.0,1/10,0.43%,DPYSL3
prerank,aminopeptidase activity (GO:0004177),-0.42505724764489605,-1.1718598451690103,0.2397094430992736,0.7137252719701681,1.0,5/26,8.27%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,mechanosensitive ion channel activity (GO:0008381),0.5502752341526496,1.171855660412235,0.2808586762075134,0.793530346739719,1.0,4/12,5.76%,TMC5;PIEZO1;TMEM63B;TMC7
prerank,SUMO transferase activity (GO:0019789),-0.4632218062228405,-1.1700976854533554,0.29539951573849876,0.7107889893216689,1.0,5/16,18.96%,HDAC4;PIAS1;PIAS2;MUL1;NSMCE2
prerank,amino acid binding (GO:0016597),0.46936211837315095,1.1691302837745008,0.2843601895734597,0.7961494439617365,1.0,10/31,20.24%,NOS3;DDAH1;NOS2;GRIN3B;SHMT2;GRIN2B;GRM7;AGXT;GLRA2;ASS1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5295707570174186,1.1670633063350875,0.29411764705882354,0.7965413527720323,1.0,3/13,9.35%,SH3BP4;CCDC88A;ARHGDIA
prerank,lysophospholipase activity (GO:0004622),0.4962149068630964,1.1651525254970378,0.3144758735440932,0.7965138319747578,1.0,5/20,8.87%,PLA2G4B;PNPLA6;GDPD1;ENPP2;LYPLA1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.45025273763667784,-1.164819286264949,0.2936893203883495,0.7183023936137878,1.0,11/20,29.52%,EHMT2;SETD7;SETD4;EEF2KMT;SETD2;SETD6;KMT5A;EEF1AKMT2;SMYD2;METTL21C;ANTKMT
prerank,protein phosphatase inhibitor activity (GO:0004864),0.46836276071827715,1.1603358076284775,0.27479674796747966,0.805620890906003,1.0,13/26,26.15%,PPP1R9B;PPP1R2;PTN;PPP1R11;PPP1R14C;PPP1R8;BOD1;PPME1;SET;ENSA;PABIR1;LMTK2;PPP1R14A
prerank,phosphoric diester hydrolase activity (GO:0008081),0.45120915917348975,1.159129916472432,0.2601246105919003,0.8035729701440341,1.0,4/35,6.04%,GPCPD1;PLCB4;PLD4;GDPD1
prerank,BMP binding (GO:0036122),0.5501156683982726,1.158392385615548,0.30782918149466193,0.8004535977972034,1.0,2/11,1.27%,ENG;BMPR2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5707827574761866,1.156192467502556,0.31992687385740404,0.8016696917902432,1.0,4/10,12.37%,PIK3R3;PIK3C3;PIK3C2A;PIK3CB
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.44796143461747945,1.1493114307898975,0.3016129032258065,0.8166782656543806,1.0,10/35,12.34%,FES;PTK2;ZAP70;LYN;FYN;YES1;HCK;PTK6;SYK;TNK2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2541555388133881,-1.1482042068208798,0.0,0.758974911883276,1.0,129/831,11.78%,FOXP2;PBX1;SOX5;MAF;NFIA;ZIC1;AEBP1;ZIC4;NR2F2;ZEB2;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;CREB5;ZFHX3;GLI2;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;FOXP4;PKNOX2;HOXC4;HOXC6;ARNT2;OSR1;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;MEOX2;NFAT5;THRB;HDAC4;CUX1;TOP1;IKZF2;MXI1;HOXB4;PRRX2;TEF;SALL1;HOXB6;NR1D2;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;PLAGL1;MLXIP;HOXA7;ZNF423;RBPJ;MKX;ZNF367;AR;GLIS2;PBX4;PPARA;PURG;HIF3A;KLF3;SIX1;NR3C2;EBF4;RUNX2;IKZF4;RORA;TBX18;ZNF25;NFXL1;HOXC8;TEAD3;HEYL;BCL6;CHD2;GLI1;PBX3;SMAD9;MEIS1;ZFAT;ZNF568;FOXJ2;EBF2;NFATC4;ATF5;ZSCAN29;KLF15;ZEB1;ELF4;RFX7;FOXL1;KDM6B;MITF;RBAK;POU6F1;ATOH8;HSF2;ZNF23;SOX6;STAT5A;MGA;FOXO3;TWIST2;ZKSCAN7;ZNF483;CEBPB;ELK1;ZNF697;ARNT;CREBRF;ZNF148;ZNF182;NR2F1;ETV1;GATA6;ZBTB38;ESR1;RXRA;RFXAP;TFCP2L1;NFX1
prerank,copper ion binding (GO:0005507),-0.3622172431019328,-1.148178626652568,0.25072886297376096,0.7511709397224837,1.0,7/42,7.21%,MOXD1;LOXL3;PAM;SOD3;ATP7A;LACC1;P2RX4
prerank,protein phosphatase regulator activity (GO:0019888),0.41048147571610827,1.1481495568512536,0.27126099706744866,0.8147053817275087,1.0,14/53,16.87%,PPP1R16B;PPP1R9B;CALM1;PPP4R1;PPP1R2;PPP2R5A;PTN;PHACTR4;B3GAT3;PPP2R2C;PPP1R15B;BOD1;PPME1;SHOC2
prerank,hyaluronic acid binding (GO:0005540),0.5679081445708225,1.1475327648734936,0.33271375464684017,0.8112003457909575,1.0,2/10,5.12%,LAYN;HYAL2
prerank,cholesterol binding (GO:0015485),0.4162462655913176,1.145596610214815,0.28059701492537314,0.8117549284942909,1.0,4/47,3.88%,PROM1;CAV1;OSBPL1A;ABCG1
prerank,galactosyltransferase activity (GO:0008378),0.5448887627587526,1.1439429740698719,0.2884990253411306,0.8113121167731945,1.0,2/11,2.36%,B4GALT5;B4GALT4
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5214980097955181,1.141168667252789,0.3127208480565371,0.8142128645359161,1.0,1/14,0.03%,SPOCK2
prerank,phospholipase C activity (GO:0004629),0.46546473810639866,1.1360798209528649,0.3165217391304348,0.8247114333445338,1.0,6/25,11.27%,PLCB1;PLCB4;PLCG1;PLCH2;PLCH1;CHRM3
prerank,lipase activity (GO:0016298),0.42341740921554216,1.1352201096302141,0.2806201550387597,0.8220187094117865,1.0,4/43,8.87%,ABHD2;LIPE;LIPC;LYPLA1
prerank,GTPase activity (GO:0003924),0.3432130360731615,1.134054005703628,0.24695863746958638,0.8205631795973628,1.0,31/192,12.80%,DNM3;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MTG1;GNA12;EFTUD2;RHOB;TBC1D24;RALB;RAB11A;RAP1B;DNM2;IRGM;GTPBP1;GPN3;RAB3B;GFM1;RAC1;HRAS;RAB4A;MMAA;GPN2;RND1;GNB1;RAB1A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5274710372916962,1.1313475345513049,0.34600760456273766,0.8233310989914534,1.0,2/11,12.91%,CNGA2;HCN2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4964017912030909,-1.1278491318087516,0.34490238611713664,0.8031130900611696,1.0,6/12,6.76%,IGF1;IRS1;SHC1;ARRB1;IGF2;GNAS
prerank,I-SMAD binding (GO:0070411),-0.477658647626783,-1.1266799437993003,0.31422505307855625,0.7986283620574998,1.0,6/13,9.15%,SMAD3;SMAD6;TGFBR1;SMAD9;TGFB1I1;AXIN1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3377886980103017,1.1248000499304351,0.22418136020151133,0.8375193652261433,1.0,31/196,12.20%,MFHAS1;INSR;RHOBTB1;PDE2A;RAPGEF2;GCH1;RAB31;GBP7;GBP4;GBP5;CNGA2;TGM2;ARF5;REM2;RHOB;RALB;RAP1B;DNM2;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;RAB3B;RAC1;EIF2B2;TUBD1;HRAS;RAB4A;MMAA;RND1
prerank,gated channel activity (GO:0022836),0.5103090135639609,1.1197863195712747,0.3374340949033392,0.8475348985422198,1.0,4/14,5.76%,TMC5;PIEZO1;TMEM63B;TMC7
prerank,lipid phosphatase activity (GO:0042577),0.5131168741627193,1.1196989070861163,0.3296903460837887,0.8424886300715086,1.0,2/14,3.78%,SGPP2;PLPP6
prerank,ligand-gated channel activity (GO:0022834),0.44211512100991496,1.1187827887893804,0.31789137380191695,0.8396487420275432,1.0,9/29,13.54%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5136683841870059,1.1183543161685976,0.3387387387387387,0.8357353313301248,1.0,2/14,2.75%,MAL;NOD1
prerank,ligand-gated ion channel activity (GO:0015276),0.43801042353846964,1.1174984348267154,0.3253968253968254,0.8330332718790209,1.0,9/30,13.54%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,O-acyltransferase activity (GO:0008374),0.44606080678053633,1.116831638310709,0.31357254290171604,0.829813573687906,1.0,16/30,26.08%,MBOAT1;AWAT2;LPCAT3;PRDX6;LRAT;MOGAT2;DGAT1;MBOAT7;LPCAT2;MBOAT2;LPCAT4;DGAT2;GPAM;GPAT4;LPCAT1;PLAAT1
prerank,G protein-coupled receptor activity (GO:0004930),0.33214226046473566,1.1165519506595598,0.2459016393442623,0.8256539259506562,1.0,41/239,17.53%,ADGRL4;ADGRE5;ADGRL2;ADGRL3;HCRTR1;S1PR1;ADGRG1;LPAR6;APLNR;CALCRL;CCR7;P2RY10;XPR1;OXTR;ADRA2B;GPR17;HCRTR2;OPN5;CXCR2;GPR22;GPR52;NPR1;ADCYAP1R1;AGTR2;CYSLTR1;TPRA1;GPR171;MTNR1A;GPR75;RXFP2;GPR85;OPN3;RXFP3;GPR62;OPRD1;SSTR1;GRM8;GLP1R;S1PR4;RRH;ADGRG3
prerank,GABA receptor binding (GO:0050811),-0.5062822561565005,-1.113648287336442,0.34505494505494505,0.8299767133393443,1.0,6/11,26.09%,TRAK1;PLCL2;ARFGEF2;SHISA7;AKAP5;LHFPL4
prerank,GTP binding (GO:0005525),0.33583249082483474,1.1136031343425352,0.2685069008782936,0.8293350683701,1.0,34/172,16.24%,MFHAS1;INSR;RHOBTB1;GCH1;RAB31;GBP7;GBP4;GBP5;TGM2;ARF5;REM2;RHOB;RALB;RAP1B;DNM2;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;RAC1;EIF2B2;TUBD1;HRAS;RAB4A;MMAA;RND1;RHOV;DYNC1LI1;TUBA1A;TUBB4B;ARL4D;GNL1;RALA
prerank,vitamin D receptor binding (GO:0042809),-0.45817490359460145,-1.1134438553721877,0.3146853146853147,0.8225076891170119,1.0,6/14,24.82%,RXRA;MED14;MED30;MED4;MED24;MED16
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3868052773655689,-1.1107314324711652,0.30412371134020616,0.8228217164493464,1.0,14/32,19.49%,KDM7A;EGLN3;KDM2A;KDM2B;P4HTM;PHF8;PHYH;TMLHE;ALKBH1;BBOX1;RIOX2;JMJD4;HSPBAP1;TYW5
prerank,sterol binding (GO:0032934),0.39459238279279657,1.1103843791792347,0.3235294117647059,0.8338312372099198,1.0,5/56,3.88%,PROM1;CAV1;OSBPL1A;OSBP;ABCG1
prerank,microtubule binding (GO:0008017),0.3300943028901261,1.1095060465059674,0.27228327228327226,0.8312627341959627,1.0,51/222,17.48%,DNM3;MACF1;MTUS1;REEP1;STARD9;ARHGEF2;MAP4;FGF13;CCDC69;KIF26A;CLIP1;MAPRE2;RP1;CCDC88A;CCDC88B;KIF2A;KIF1A;RAB11A;DNM2;MAP6D1;MARK4;MAP1LC3B;EML5;CDK5RAP2;EML6;DCX;MID1;HAUS6;KIF3B;HOOK1;MAP4K4;PEX14;CRIPT;S100A8;MAP10;KIF23;TERF1;POLB;MAPRE3;EML1;CKAP5;SPAG5;RCC2;APC;REEP3;SPAST;CAMSAP2;TRPV4;CCDC66;CLIP2;MAP1LC3A
prerank,small GTPase binding (GO:0031267),0.33777033455754113,1.1059241901582857,0.27581863979848864,0.8369113066188612,1.0,31/169,13.32%,DOCK4;FGD5;SRGAP2;SH3BP4;CAV1;UNC13B;ARHGEF2;RIN3;PEX5L;EPS8;USP6NL;PKN1;RAPGEF4;OCRL;UNC13D;NCKAP1;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;CYFIP1;BICDL1;KIF3B;EXOC4;EXOC2;TBC1D30;RANBP9;CYRIB;TMEM127;FGD2
prerank,microtubule motor activity (GO:0003777),0.3978844091784245,1.1052851510103756,0.33281972265023113,0.8339358785307187,1.0,9/51,12.72%,STARD9;KIFC3;DNAH3;KIF26A;KIF2A;KIF1A;KIF3B;KIF23;DNAH8
prerank,tubulin binding (GO:0015631),0.3209132153864979,1.1047976271980953,0.23708920187793428,0.830461331643346,1.0,53/295,12.53%,DNM3;TTLL7;MTUS1;EFHC2;REEP1;STARD9;ARHGEF2;MAP4;FGF13;DIP2B;CCDC69;STMN1;KIF26A;CLIP1;TTLL5;MAPRE2;RP1;CCDC88A;FYN;CCDC88B;KIF2A;KIF1A;STMN3;RAB11A;DNM2;STMN4;MAP6D1;MARK4;BRCA2;MAP1LC3B;EML5;TRIM36;ARHGEF7;CDK5RAP2;AGBL5;PAK1;EML6;RITA1;DCX;MID1;HAUS6;KIF3B;HOOK1;MAP4K4;PEX14;CRIPT;CCT5;S100A8;MAP10;KIF23;TERF1;POLB;MAPRE3
prerank,channel activity (GO:0015267),0.4102326259399759,1.1007794458002715,0.3411580594679186,0.8370018409582448,1.0,4/41,7.23%,AQP11;MCUB;AQP7;CHRNB1
prerank,nucleotidyltransferase activity (GO:0016779),0.47233579250028085,1.1006065746247151,0.38392857142857145,0.8326624296113252,1.0,2/19,5.07%,TENT4A;MTPAP
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.43837172045742584,-1.0983271245173982,0.3380281690140845,0.8512546509113431,1.0,5/17,13.14%,DPYD;BDH2;PTGR2;PECR;DECR1
prerank,protein kinase inhibitor activity (GO:0004860),-0.3461663879135716,-1.0940074596486755,0.30158730158730157,0.8566237437383961,1.0,10/42,18.62%,PARVA;GMFB;QARS1;SPRED1;IBTK;DUS2;CDKN1C;DNAJC3;MAPK8IP1;SMCR8
prerank,translation initiation factor activity (GO:0003743),0.41292355759989263,1.0928419085008019,0.329073482428115,0.8504973600855686,1.0,14/36,16.68%,EIF3F;EIF3E;EIF2B1;EIF3D;MTIF3;EIF2B2;EIF4E;EIF3G;EIF3B;EIF3L;EIF3M;EIF1B;EIF4A1;COPS5
prerank,receptor tyrosine kinase binding (GO:0030971),0.3835695946020444,1.0912093291728058,0.3379204892966361,0.8503385456632689,1.0,8/56,10.57%,GRB14;DOCK4;DUSP3;ELMO2;HYAL2;SHC3;SOCS5;ACP4
prerank,glucuronosyltransferase activity (GO:0015020),0.47652410766784675,1.0908242355762183,0.38671209540034074,0.846521776354765,1.0,1/19,0.34%,CSGALNACT1
prerank,ATP hydrolysis activity (GO:0140603),0.4116068617973491,1.0901281635009274,0.33075734157650694,0.8436210608318346,1.0,6/41,11.09%,MYO1E;KIF26A;ABCA3;ATP2B1;DNA2;ABCD1
prerank,transcription coregulator binding (GO:0001221),-0.3433577123581891,-1.0897399181990577,0.28532608695652173,0.8616631838693434,1.0,15/50,11.97%,SMAD3;THRB;PER3;CCNT2;USP11;NEK6;EHMT2;AR;PER2;RORA;LCOR;MED25;VGLL4;ESR1;PGR
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4161276881968313,-1.0888532431009441,0.3767441860465116,0.8563310050656306,1.0,8/19,21.87%,AMFR;LCOR;PRKN;SELENOS;SYVN1;PTEN;SPATA2;DERL1
prerank,calcium channel inhibitor activity (GO:0019855),0.522240742450268,1.0867232891901937,0.39464285714285713,0.8490667882167399,1.0,3/11,4.40%,MCUB;SLC30A1;CALM1
prerank,triglyceride lipase activity (GO:0004806),0.4713683962234647,1.0859074044680705,0.3986135181975737,0.8464869360599676,1.0,2/20,7.28%,LIPE;LIPC
prerank,microtubule minus-end binding (GO:0051011),0.5032784796364201,1.0856987585655142,0.370304114490161,0.8423806361270572,1.0,1/13,1.09%,MACF1
prerank,anion channel activity (GO:0005253),0.37799149361392453,1.0846286802691678,0.3505747126436782,0.8408972447018621,1.0,21/61,19.80%,LRRC8B;LRRC8C;CLCA2;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;GPR89A;GPR89B;LRRC8D;CLCN7;GABRG1;CLIC1;CLCC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.46606906209629967,1.083260110727489,0.37543859649122807,0.8403121750116349,1.0,12/19,26.19%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GRID1;GABRA2;GABRG2
prerank,sequence-specific DNA binding (GO:0043565),-0.24309516742212428,-1.0805274356028762,0.1935483870967742,0.8739418454345157,1.0,85/590,11.76%,FOXP2;PBX1;MAF;ZIC1;ZIC4;NR2F2;ZEB2;GLI3;RARB;ZBTB20;CREB5;GLI2;FOXD1;HLF;SMAD3;PKNOX2;HOXC4;ARNT2;OSR1;TEAD1;NR6A1;HOXA5;MEOX2;NFAT5;THRB;HDAC4;CUX1;HOXB4;PRRX2;TEF;HOXB6;NR1D2;FOXC2;FOXC1;TBX15;PPARGC1A;HOXA7;ZNF423;RBPJ;GLIS2;PBX4;PPARA;KLF3;SIX1;NR3C2;RUNX2;RORA;TBX18;HOXC8;BCL6;KDM2A;SIRT3;FOXJ2;NFATC4;ATF5;ZSCAN29;KLF15;ELF4;VSX1;RFX7;BCL2;FOXL1;KDM5B;FBXL19;KDM2B;POU6F1;HSF2;ZNF23;FOXO3;CXXC5;CEBPB;CREB3L1;ELK1;ARNT;ZNF148;NR2F1;ETV1;CXXC4;GATA6;ZBTB38;ESR1;RXRA;PRMT5;KDM1A;TFCP2L1
prerank,1-phosphatidylinositol binding (GO:0005545),0.4827239484130526,1.0785603469444138,0.398972602739726,0.8491798572008927,1.0,3/15,7.16%,SCARB1;EPB41;WDFY3
prerank,iron ion binding (GO:0005506),-0.3334944740494261,-1.0768598236830431,0.32577903682719545,0.8773637513009481,1.0,19/48,29.97%,AGMO;AOX1;KDM7A;EGLN3;FXN;PHF8;PHYH;ALKBH1;FDX1;TYW5;PHF2;DNAJC24;FTL;TET1;ACO2;FBXL5;SCD;ACP5;HAAO
prerank,translation elongation factor activity (GO:0003746),0.49493412729155983,1.0766949928848368,0.4020797227036395,0.8495539786364892,1.0,7/14,22.87%,GTPBP1;EIF5AL1;EIF5A;GFM1;EEFSEC;GTPBP2;EEF1B2
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.32791200985315566,-1.076367046512295,0.2996845425867508,0.870856948428481,1.0,14/60,13.59%,CTDSPL;PPM1E;LRRK1;CDC14B;PHLPP2;PPM1D;MTMR3;PPM1B;PPEF2;PPP1R3C;PPP3CB;CTDSPL2;LRRK2;PTEN
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.47163046216899135,-1.0753520721461776,0.3747072599531616,0.8662138836595046,1.0,7/12,23.33%,KDM7A;KDM3B;PHF8;KDM1A;PHF2;KDM4D;HR
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4544199367679694,1.0742077679141084,0.36180904522613067,0.8519686153264474,1.0,4/20,10.03%,TJP2;MAGI3;AK4;CMPK1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4819163842720634,-1.074104401952501,0.39740820734341253,0.862559661683338,1.0,2/11,3.28%,EGFR;MAP3K5
prerank,GTPase inhibitor activity (GO:0005095),-0.4491055119454112,-1.072390463906434,0.3776223776223776,0.8604096096995993,1.0,5/13,20.12%,CPEB2;SLIT2;GPS2;RHOH;IQGAP2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3671976058448088,-1.070670918944776,0.3324742268041237,0.8580070931250788,1.0,13/33,25.10%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;SPTY2D1;ELP4;WAC;UVSSA;ERBB2;SMYD2
prerank,methyl-CpG binding (GO:0008327),-0.40219751123386904,-1.0694566923901427,0.39485981308411217,0.8540323475738536,1.0,15/22,35.48%,CXXC5;CXXC4;ZBTB38;PRMT5;ZBTB4;MBD2;ERH;TET1;ZCWPW1;UHRF1;MBD3;MBD1;PRMT1;LRWD1;LHX4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2666284508024036,-1.0684764018743547,0.25396825396825395,0.8494433394642723,1.0,36/188,11.50%,BNC2;PBX1;SOX5;ZBTB20;SMAD3;SMAD6;HDAC4;GABPB2;PER3;CREB3L2;FOXC2;BCOR;FOXC1;TBL1XR1;AR;PER2;GLIS2;SIX1;TBX18;GLI1;ZNF568;ATF5;KLF15;CHD3;VSX1;YAP1;SOX6;FOXO3;CEBPB;CREB3L1;ELK1;RNF10;CRY2;GATA6;MTERF3;RXRA
prerank,kinase activity (GO:0016301),0.3441057977870894,1.0672550418079765,0.33918918918918917,0.867011796086128,1.0,22/109,13.83%,ITPKB;DGKH;PRKD1;LYN;PRKD3;DGKI;EPHA4;DGKE;PKN2;CHKA;CERKL;PGM2L1;PDXK;PIK3C3;PIK3C2A;MAP4K4;IPMK;DGKZ;PIK3CB;PANK3;CERK;PSTK
prerank,chloride transmembrane transporter activity (GO:0015108),0.48327145506153685,1.0662592053346387,0.40819964349376114,0.8652243081196652,1.0,1/16,0.40%,SLC1A1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4285965408741456,1.0651658107918796,0.37891268533772654,0.863925465105519,1.0,3/24,10.03%,ITPKB;AK4;CMPK1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.330634142386313,-1.0651248811435512,0.335243553008596,0.8519485506767842,1.0,12/53,12.58%,MICAL3;DDO;MICAL2;AOX1;DPYD;POR;NOX4;PRODH;MTHFR;CRY2;KDM1A;AIFM2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.4698882592058773,1.0644813435231175,0.41228070175438597,0.8610849882388858,1.0,9/17,23.57%,GRIN3B;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIA2;GRIK3;GRIN1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.4502724195254147,1.0642258862348661,0.4043321299638989,0.8572658320291864,1.0,1/21,0.27%,POLK
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5044824895308269,1.0638530493125058,0.4003690036900369,0.853791333568705,1.0,4/11,17.56%,KCNQ1;KCNH2;KCNJ5;KCNJ3
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.40772532988953375,1.0633516263257334,0.38338658146964855,0.8508128729833462,1.0,21/35,32.07%,TAF1B;STAT1;RRN3;POU2F1;GTF2B;ZBTB17;NR3C1;UBTF;TAF4;TBPL1;FOXP1;TAF1C;SMARCA4;MYC;SNAPC3;AGO1;PARK7;TP53;DR1;MMP12;H3-3A
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4105259527686213,1.0626734036924248,0.38057324840764334,0.8482291679514615,1.0,11/33,20.75%,CNOT6L;NOCT;PAN2;PDE12;DCP2;CNOT6;DIS3L;XRN1;EXOSC10;EXOSC9;XRN2
prerank,neuropeptide receptor binding (GO:0071855),0.4892606590411853,1.0626339256516277,0.4187725631768953,0.8439964869912953,1.0,3/14,18.94%,NPPA;PPY;NTS
prerank,cytokine receptor activity (GO:0004896),0.3558752044932206,1.0625418513144878,0.3659574468085106,0.839935846166709,1.0,17/83,13.17%,IL1R1;IL6R;IFNAR1;FZD4;IFNAR2;IL10RB;OSMR;CD4;IL17RD;IL13RA2;IL4R;GPR17;LIFR;EBI3;IL20RB;IL27RA;IL7R
prerank,palmitoyltransferase activity (GO:0016409),0.42245623496885043,1.0609429890524849,0.36904761904761907,0.840221610383078,1.0,6/28,9.99%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,RNA stem-loop binding (GO:0035613),-0.45837798768601523,-1.0592342862099677,0.4004474272930649,0.8616806749663669,1.0,5/12,24.09%,EPRS1;FMR1;DDX3X;LARP6;CSDE1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.49491455770145437,1.0582134280829392,0.40613718411552346,0.8436060411335602,1.0,4/12,3.16%,ENG;BMPR2;LTBP4;ACVRL1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.45774342378902777,1.0572723379362514,0.41289198606271776,0.8419195241530939,1.0,4/18,3.16%,ENG;BMPR2;LTBP4;ACVRL1
prerank,DNA polymerase activity (GO:0034061),0.4426579121608839,1.055019912991833,0.4111310592459605,0.84373377276676,1.0,1/22,0.27%,POLK
prerank,WW domain binding (GO:0050699),0.4162995598851859,1.050274345042894,0.3973941368078176,0.8521115175837541,1.0,6/26,17.92%,RAPGEF2;NDFIP2;TNK2;TCEAL6;TCEAL5;DAZAP2
prerank,intracellular chloride channel activity (GO:0061778),0.4682098740063601,1.0489113962768384,0.43309859154929575,0.8472558504625918,1.0,5/16,19.80%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.4682098740063601,1.0489113962768384,0.43309859154929575,0.8472558504625918,1.0,5/16,19.80%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.44866801458195327,-1.0478959696587715,0.4090909090909091,0.8888002750320392,1.0,2/11,7.70%,ITPR1;RASA3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.47398378548805253,1.0436601961360181,0.43716814159292033,0.856802160854668,1.0,2/15,5.09%,SLC1A1;SLC1A2
prerank,histone deacetylase binding (GO:0042826),0.3416646847862496,1.0408409055740924,0.40668523676880225,0.8599596731874579,1.0,9/88,8.56%,LEF1;MEF2C;HDAC9;HSP90AB1;TAL1;PKN1;PKN2;INSM1;FOXP3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.48055812051765673,1.0384151701096587,0.4468864468864469,0.8621564940324397,1.0,4/12,18.96%,STAT1;POU2F1;GTF2B;TBPL1
prerank,protein kinase regulator activity (GO:0019887),-0.29047118338165,-1.0380847136994737,0.3684210526315789,0.9113427437638244,1.0,23/95,16.00%,PRKAG2;PARVA;CCNT2;GPRC5C;GMFB;CCNL1;CCND2;QARS1;ELP3;PRKAG3;STK11;CCNC;CCNH;ANKRD54;STRADA;WNK1;WNT11;DUS2;CCNE2;ELP4;GPRC5A;CDKN1C;DNAJC3
prerank,syntaxin-1 binding (GO:0017075),0.4296192792865926,1.0347816493195516,0.42784380305602715,0.8678143092634334,1.0,6/22,14.16%,UNC13B;SYPL1;STXBP1;SYNPR;CPLX1;SYPL2
prerank,carboxy-lyase activity (GO:0016831),0.42723895932815864,1.0340366021895746,0.42517006802721086,0.8655897919422029,1.0,1/23,0.62%,DDC
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4309626194158348,-1.0319836907375874,0.42691415313225056,0.9219946235757879,1.0,4/13,15.27%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4315615395556083,-1.0311122842587876,0.4340909090909091,0.9171537132685837,1.0,7/14,30.72%,ALDH4A1;MTHFD1;MTHFR;PYCR3;AASS;PYCR1;ALDH1L1
prerank,actinin binding (GO:0042805),0.4331858499842577,1.031042945360856,0.4080267558528428,0.8690543364814435,1.0,2/21,2.04%,PROM1;MAGI1
prerank,nuclear receptor binding (GO:0016922),0.32917406661893617,1.0301571650132537,0.4217335058214748,0.8671188001483708,1.0,18/111,12.56%,LEF1;NCOA1;CTNNB1;PKN1;ACTN4;STAT1;TACC1;BUD31;NCOA2;YWHAH;ARID1A;HMGA1;OASL;SRARP;ZBTB7A;HIF1A;PRKCB;GTF2B
prerank,voltage-gated anion channel activity (GO:0008308),-0.4255954296929734,-1.0282584125850327,0.42596810933940776,0.9185240819802841,1.0,4/15,9.26%,ANO6;CLCN2;ANO1;CLCN6
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4658006832931539,1.0279473905086545,0.43613138686131386,0.8689616783661829,1.0,1/16,0.40%,SLC1A1
prerank,RNA polymerase II complex binding (GO:0000993),-0.3467586083526295,-1.021108788891088,0.4304812834224599,0.9330553716351117,1.0,8/32,15.31%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4
prerank,signal sequence binding (GO:0005048),0.3831450752072423,1.0185985719695214,0.4405144694533762,0.8894027944373046,1.0,10/35,19.61%,NFKBIA;PEX5L;CAT;AP2M1;RANBP6;AP2B1;TOMM20L;NUP153;KCNIP2;IPO4
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.4406836045553054,-1.018273227227286,0.4392935982339956,0.9344599189395849,1.0,7/12,36.78%,AIFM2;NQO1;CRYZ;DCXR;CRYZL1;DHRS4;CBR1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.4539553569397246,-1.0177067647304365,0.47391304347826085,0.9285361371714719,1.0,5/10,14.04%,CACNA1C;CACNA1D;CACNB4;CACNB2;CACNB1
prerank,tropomyosin binding (GO:0005523),-0.415585897060874,-1.0160603750113644,0.4423963133640553,0.9260066135890483,1.0,6/16,17.22%,CALD1;S100A6;LMOD1;TMOD3;TNNT3;TMOD2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3899177027825651,1.015600549912503,0.4391785150078989,0.8931061082899912,1.0,10/34,20.75%,CNOT6L;NOCT;PAN3;PAN2;PDE12;CNOT6;DIS3L;EXOSC10;EXOSC9;XRN2
prerank,heme binding (GO:0020037),0.3545402265599139,1.0145153332391181,0.43478260869565216,0.891847652456625,1.0,11/65,10.63%,NOS3;FLVCR2;CYP2E1;PXDN;NOS2;CYP11B1;CYP11A1;CAT;TBXAS1;CBS;CYBB
prerank,titin binding (GO:0031432),-0.424181339682118,-1.014127286948366,0.4298642533936652,0.9246135617169704,1.0,3/13,10.27%,ACTN2;CAMK2D;TRIM63
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.24855986830768284,-1.0133622730966527,0.4294478527607362,0.9194962093973784,1.0,50/232,15.96%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;PIAS1;DTX3;DTX4;RNF145;DTX1;RNF217;SH3RF2;MGRN1;TRAF3IP2;PRKN;UBR5;RNF135;SMURF2;LRSAM1;CUL3;TRIM63;HUWE1;KCMF1;RNF10;WWP2;NHLRC3;PPIL2;NFX1;RNF181;PRPF19;PIAS2;MYLIP;RNF24;FBXO17;PELI3;RNF149;SYVN1;TRIM9;RNF121;NSMCE1;TRIP12;UBR2;UBR3;RCHY1;MKRN1;RNF144A
prerank,ion channel activity (GO:0005216),-0.28760422602170205,-1.0132020198711222,0.43944636678200694,0.9129158607676912,1.0,10/80,8.71%,TRPM3;NALCN;PIEZO2;PKD2;TRPM6;ABCC9;ANXA6;CALHM2;CALHM5;TRPC6
prerank,ATPase regulator activity (GO:0060590),-0.33599331549211753,-1.0112227795483326,0.45187165775401067,0.9120535768024162,1.0,12/38,20.97%,FNIP1;SIL1;ATP1B3;ATP1B2;BAG1;TOR1AIP1;ATP5IF1;BAG3;DNAJB4;DNAJB2;TSC1;DNAJC24
prerank,histone methyltransferase binding (GO:1990226),0.47695751297152994,1.0112206132515458,0.4566787003610108,0.896475411732127,1.0,3/11,9.20%,CTNNB1;HSP90AB1;LCORL
prerank,phosphatase inhibitor activity (GO:0019212),0.43669816927975313,1.0106261252675612,0.46260869565217394,0.8939950334739192,1.0,8/20,25.20%,PPP1R9B;PPP1R2;PTN;BOD1;PPME1;SET;ENSA;LMTK2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.38052254888777687,-1.0106173747041474,0.467005076142132,0.9065493722428238,1.0,3/22,4.82%,SCN7A;PKD2;CACNA1G
prerank,methylation-dependent protein binding (GO:0140034),-0.30342876333968005,-1.0074257803514628,0.45664739884393063,0.9089815041252108,1.0,12/57,14.97%,ZMYND8;PYGO1;KDM7A;SGF29;CBX5;CHD8;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3739556165199803,-1.0049322876719213,0.4431279620853081,0.909873633762865,1.0,4/19,10.80%,ITPR1;P2RX4;RASA3;TRPM4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3710764315129501,1.002533003640004,0.4599358974358974,0.9113202543442531,1.0,2/44,3.49%,MECOM;MEN1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4071294967475087,1.0002836453780668,0.46218487394957986,0.9129416030021841,1.0,5/26,13.57%,CSGALNACT1;B3GNT2;B4GALNT1;B3GALT4;B3GALT2
prerank,myosin binding (GO:0017022),-0.30992203199203794,-0.999911390070883,0.4526627218934911,0.9176270039179424,1.0,5/55,3.30%,CALD1;KIRREL1;GSN;TRAK1;DMD
prerank,cAMP response element binding (GO:0035497),-0.4675905518862933,-0.9950699344713594,0.4955947136563877,0.9250444412981579,1.0,5/10,14.59%,CREB5;CREB3L2;CREB3L1;E4F1;ATF2
prerank,anion:anion antiporter activity (GO:0015301),-0.4052741550182234,-0.9941703628091706,0.48564593301435405,0.9208686395636967,1.0,6/17,23.70%,SLC26A7;SLC26A2;SLC4A2;SLC4A3;SLC26A11;SLC26A6
prerank,ion channel inhibitor activity (GO:0008200),0.381015342631325,0.9931573050033564,0.4712460063897764,0.9270755022994719,1.0,5/35,4.40%,NEDD4L;STX1A;MCUB;SLC30A1;CALM1
prerank,protein kinase C binding (GO:0005080),0.3673239916697541,0.993010969890604,0.4700460829493088,0.9232133638644863,1.0,16/43,17.37%,TIRAP;PRKD2;HDAC9;HDAC7;HINT1;PKN1;CCDC88A;ADCY4;TWF2;CAVIN2;HSPB1;PRKCB;HDAC5;NELL2;TRPV4;NELL1
prerank,NAD+ binding (GO:0070403),-0.4240987828110544,-0.9929872198997207,0.49671772428884026,0.9175017183855807,1.0,5/12,23.12%,CRYL1;SIRT3;SIRT2;HADH;SIRT6
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32633654354595887,-0.9926416201520951,0.4728682170542636,0.9118047089110719,1.0,6/38,6.95%,SERPING1;TFPI;ANXA2;SERPINH1;SERPIND1;SERPINF1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.34928573313877714,-0.9912697744845969,0.4748743718592965,0.9090023241360561,1.0,7/27,21.92%,LRP1;APOE;HSP90B1;APBB3;AP2A1;SNX17;LANCL1
prerank,ubiquitin protein ligase activity (GO:0061630),-0.24295889463479695,-0.9903373461446062,0.5337423312883436,0.9050106772665772,1.0,49/228,15.96%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;DTX3;DTX4;RNF145;DTX1;RNF217;SH3RF2;MGRN1;TRAF3IP2;PRKN;UBR5;RNF135;SMURF2;LRSAM1;CUL3;UBE4B;TRIM63;HUWE1;KCMF1;RNF10;WWP2;NHLRC3;PPIL2;NFX1;RNF181;PRPF19;MYLIP;RNF24;FBXO17;PELI3;RNF149;SYVN1;TRIM9;RNF121;NSMCE1;TRIP12;UBR2;UBR3;RCHY1;MKRN1;RNF144A
prerank,N-acetyltransferase activity (GO:0008080),-0.3802639125230737,-0.9873494470991298,0.45496535796766746,0.9071714828897942,1.0,10/19,33.58%,SAT1;NAA80;EP300;SAT2;NAT2;NAT8L;NAA50;AANAT;SMARCE1;ESCO1
prerank,chemokine binding (GO:0019956),-0.34706396253131255,-0.9867206558996924,0.45843828715365237,0.9024362911074502,1.0,4/30,10.48%,PDPN;CCR9;FGF2;ITGAV
prerank,cation:chloride symporter activity (GO:0015377),-0.4426057778654315,-0.9865983488409698,0.46060606060606063,0.8965429489919605,1.0,4/10,13.19%,SLC12A2;SLC6A1;SLC12A7;SLC12A4
prerank,endopeptidase inhibitor activity (GO:0004866),0.3307527968227567,0.9853781170949262,0.48863636363636365,0.9394431864969435,1.0,18/82,17.73%,SPOCK2;APP;SERPINB5;SERPINA9;SERPINA11;BST2;PZP;CST7;SPOCK1;SERPINI1;ITIH3;SLPI;PTTG1;SERPINC1;CSTB;BIN1;SERPINB9;UBE2Z
prerank,metal ion binding (GO:0046872),0.27863207302798776,0.9853704764290704,0.5178378378378379,0.9352104716002281,1.0,79/477,14.31%,SPOCK2;CSGALNACT1;RASGRP3;ESYT2;LTBP4;PDE2A;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;STK38;SPARCL1;AGRN;SNRK;HPRT1;SNN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;NT5C3A;CDH8;MTPAP;CAMKK2;PIR;SYT7;PRKACB;ESYT1;RASGRP2;IDH3A;RET;DCHS1;CDH19;SRI;CRNN;MAP3K6;CETN2;IQGAP1;PDXK;ENPP2;SPOCK1;NRXN1;LETM1;HPGDS;DNER;CLGN;NUDT3;TPM4;LRP2;PPP3CA;S100A8;SYT4;CDH23;PPP3R1;CDH10;DXO;CPNE6;CALB2;EML1;MAN1B1;CERK;HACL1;STK3;FAN1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;CDH5;XYLT2;MOV10L1;PDCD6
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2339601053065686,-0.9848242477459426,0.46846846846846846,0.894938659830945,1.0,76/346,17.66%,RNF220;PDZRN3;RNF152;PELI2;UBE2E2;RNF43;SH3RF3;CBLB;AMFR;BCOR;ASB2;TTC3;DTX3;DTX4;TRIM23;FBXO10;RNF145;FBXW8;DTX1;RNF217;SH3RF2;UBE2R2;MGRN1;TRAF3IP2;PRKN;PJA2;UBE2E1;UBR5;RNF214;RNF135;PML;UBE2M;SMURF2;LRSAM1;DDB2;RNF31;CUL3;BTRC;TRIM63;HUWE1;KCMF1;RNF10;WWP2;NHLRC3;AKTIP;UBE2E3;RNF20;KLHL13;PPIL2;NFX1;RNF181;PRPF19;MYLIP;RNF24;FBXO17;PELI3;RNF149;SYVN1;TRIM9;FBXW11;RNF121;KLHL42;NSMCE1;UBE2B;TRIP12;UBR2;UBR3;RCHY1;MKRN1;RNF144A;DTX2;FBXO4;TRAIP;FBXO9;MEX3C;UBE2Q1
prerank,transferrin receptor binding (GO:1990459),-0.4403538305080861,-0.98296517761984,0.4849699398797595,0.8940700149265889,1.0,4/10,15.19%,RGMA;CHUK;CD81;IKBKG
prerank,potassium ion antiporter activity (GO:0022821),-0.40319812590413084,-0.9829105917899886,0.48423423423423423,0.8881506599222713,1.0,5/15,11.87%,SLC24A3;SLC9A2;SLC9A9;SLC9A1;SLC24A5
prerank,aspartic-type peptidase activity (GO:0070001),-0.43940998997835534,-0.980894747292471,0.474120082815735,0.8878137273971117,1.0,2/10,12.73%,BACE2;PSEN1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35599465444363654,0.9788807920033782,0.487627365356623,0.9480810038681909,1.0,9/49,12.73%,ESYT2;DYSF;PLA2G4B;CPNE8;SYT7;ESYT1;CPNE5;SYT4;CPNE6
prerank,NAD binding (GO:0051287),-0.34902850455369194,-0.9757883759911676,0.5214105793450882,0.895412910507324,1.0,5/26,8.22%,ALDH1A1;CRYL1;ME1;SIRT3;BDH2
prerank,calcium ion binding (GO:0005509),0.28410660942995547,0.9756581568666665,0.550561797752809,0.9523283133529225,1.0,48/323,13.18%,SPOCK2;RASGRP3;ESYT2;LTBP4;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;SPARCL1;AGRN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;CDH8;CAMKK2;SYT7;ESYT1;RASGRP2;RET;DCHS1;CDH19;SRI;CRNN;CETN2;IQGAP1;ENPP2;SPOCK1;NRXN1;LETM1;HPGDS;DNER;CLGN;TPM4;LRP2;PPP3CA;S100A8;SYT4;CDH23;PPP3R1;CDH10;CPNE6;CALB2;EML1;MAN1B1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.44347016437708814,0.9754023960423086,0.49016100178890876,0.9487218253273396,1.0,5/13,18.11%,PIKFYVE;PIK3C2A;PIP4K2A;PIK3CB;PIP5K1B
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.32641830164034646,-0.974549824208318,0.503957783641161,0.8927617331887063,1.0,8/34,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UFC1;UBE2B;UBE2Q1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.4266274710100946,-0.9740373398553479,0.49464668094218417,0.888249141187955,1.0,2/11,17.69%,SLC22A4;SLC25A29
prerank,MAP kinase activity (GO:0004707),-0.3933889821246861,-0.9725060977425625,0.4966442953020134,0.8865435647217663,1.0,1/14,0.66%,MAPK4
prerank,endopeptidase activator activity (GO:0061133),0.4732892579078924,0.9714208568318361,0.4980544747081712,0.9550376894265054,1.0,7/10,27.74%,PSME2;APH1A;VSIR;NLRC4;APH1B;PSME1;ADRM1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.45129286952621694,0.9713825653554381,0.4936936936936937,0.9509184039243397,1.0,5/15,12.37%,PIK3R3;PIKFYVE;PIK3C3;PIK3C2A;PIK3CB
prerank,nuclear localization sequence binding (GO:0008139),0.42542934464455706,0.9707167466333396,0.5081967213114754,0.9485856594308346,1.0,4/18,19.61%,NFKBIA;RANBP6;NUP153;IPO4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3902032375799091,-0.9699312072270575,0.5046948356807511,0.887700863381133,1.0,4/15,15.27%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4087518821879968,-0.968535547256411,0.4924078091106291,0.885553021479835,1.0,1/13,0.82%,PLPP3
prerank,N-methyltransferase activity (GO:0008170),-0.37724104657506624,-0.9683850812225502,0.5096618357487923,0.8802677813553617,1.0,8/20,33.30%,HNMT;NNMT;TRMT1L;FDXACB1;DIMT1;RNMT;PEMT;PRMT1
prerank,transcription cis-regulatory region binding (GO:0000976),0.27401789006312205,0.9664263534954538,0.5427302996670367,0.9556991037481638,1.0,42/406,9.32%,LEF1;ETS1;FLI1;DACH1;EPAS1;ELK3;ZBTB46;SOX17;MEF2C;SMARCA2;SOX13;MEN1;PRDM2;IRF2;FOXF1;HHEX;RREB1;SOX7;TCF23;BARHL1;KLF1;SNAI2;ETV6;TAL1;TCF7;ACTN4;KLF4;MAX;SOX18;HINFP;PHOX2A;SOX12;JUN;KCNH2;TCF12;ZFP69;ATF6B;PRDM9;ZBTB14;CDK5RAP2;SIM1;HMGA1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3480389509972095,-0.9624176566778291,0.5128865979381443,0.8902873171291027,1.0,6/27,6.32%,SLC26A7;SLC26A2;SLC39A14;SLC22A6;SLC5A5;ANO1
prerank,transition metal ion binding (GO:0046914),-0.2287693731869119,-0.9606700070486878,0.6138613861386139,0.889222775815807,1.0,61/397,11.50%,MPPED2;AGMO;GLI2;TIMP2;MOXD1;SMAD3;LARGE1;PAPPA;AOX1;ENPP1;SEC24D;ZFPM2;HDAC4;MMP16;ACER3;SEC24A;CBLB;ANPEP;LOXL3;PAM;ME1;ADCY2;ZMYND8;BAZ1B;KDM7A;MDM4;ENPP3;IKZF4;SOD3;UPB1;TDP2;ATP7A;KDM2A;LACC1;SIRT3;P2RX4;PRKN;SOD2;CHD3;ZEB1;ACE;KDM5B;FBXL19;ENPEP;NPEPPS;KDM2B;EEA1;CHD4;RBAK;PTGR2;ADAM33;CXXC5;B4GALT1;IDE;CRIP1;SEC23A;FAM20C;EPRS1;CXXC4;PHF8;RXRA
prerank,wide pore channel activity (GO:0022829),0.39234022624662085,0.9554683339126873,0.5106382978723404,0.9796137242599138,1.0,2/23,1.80%,GJD3;GJC1
prerank,ephrin receptor binding (GO:0046875),0.4088738175905554,0.9548653152993959,0.5283018867924528,0.9768245846835647,1.0,6/21,7.82%,ANKS1A;LYN;GRB2;FYN;EFNA1;ANKS1B
prerank,ligand-gated cation channel activity (GO:0099094),0.32315677509450297,0.9544414423069008,0.5378151260504201,0.9736773845186883,1.0,17/75,18.27%,MCOLN1;KCNK6;CHRNB1;GRIN3B;KCNH2;GRIA4;KCNN2;P2RX7;KCNN3;GRIN2B;GRIK5;GRIK2;GRIK1;TRPM8;KCNJ5;KCNJ3;KCNJ6
prerank,carboxylic acid binding (GO:0031406),0.36648256747765995,0.9541026525912211,0.5156739811912225,0.9703324381216253,1.0,8/38,15.23%,NOS3;NOS2;SESN3;GRIN3B;SHMT2;GRIN2B;MAG;GRM7
prerank,pyridoxal phosphate binding (GO:0030170),-0.36065714441179014,-0.9539900525170307,0.52,0.9015161378160228,1.0,10/20,28.59%,PYGB;PYGM;ABAT;OAT;ACCS;THNSL2;PNPO;PYGL;SHMT1;GLDC
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4387220833863287,0.9536948679461111,0.5146520146520146,0.9671712198005268,1.0,5/13,13.65%,KCNQ1;PRKAR2B;PRKAR2A;GSK3A;SOX9
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.33110822525588524,-0.9530687464940863,0.5013054830287206,0.898139948798116,1.0,4/29,3.52%,SLC13A3;SLC26A7;SLC26A2;SLC1A5
prerank,neurexin family protein binding (GO:0042043),-0.4273263642673625,-0.9513229010183257,0.5168776371308017,0.8971962649672595,1.0,2/10,6.10%,NLGN2;SYTL5
prerank,calcium channel regulator activity (GO:0005246),0.36121716718504043,0.9506731926884335,0.5310457516339869,0.9708843188727524,1.0,7/37,9.31%,MCUB;SLC30A1;PRKG1;CALM1;REM2;SRI;NRXN1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.417753730177412,-0.9506312995308728,0.5271966527196653,0.8933980919841724,1.0,4/11,5.44%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.43195154986776707,0.9482534979542687,0.5289855072463768,0.972828189347132,1.0,3/14,10.58%,MINDY1;ATXN3;MINDY2
prerank,NF-kappaB binding (GO:0051059),0.3865368348572037,0.9482527435121411,0.5068027210884354,0.9687060360024408,1.0,6/24,19.79%,NFKBIA;FOXP3;BCL10;TAF4B;CPNE1;COMMD7
prerank,gap junction channel activity (GO:0005243),0.39571662073136393,0.9482111043484206,0.5223140495867769,0.9646991019814747,1.0,2/22,1.80%,GJD3;GJC1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3749567655095358,0.9470650201120094,0.5200642054574639,0.9633900611161866,1.0,9/29,20.47%,GCH1;PTPRJ;DUSP7;DUSP1;DUSP16;DUSP8;TNIP1;ATF7;DUSP6
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.45616629329578773,0.9464810997466023,0.5476190476190477,0.9609039682985528,1.0,4/11,14.06%,PPP1R2;PPP1R11;PPP1R14C;PPP1R8
prerank,methylated histone binding (GO:0035064),-0.28097150381082087,-0.945860474052223,0.5784883720930233,0.9003984223249799,1.0,12/62,14.97%,ZMYND8;PYGO1;KDM7A;SGF29;CBX5;CHD8;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.36877736654711313,-0.9458053161929799,0.5165094339622641,0.8949939268389009,1.0,5/18,11.53%,ALDH1A1;ALDH1A2;AKR1B1;AKR1B10;ALDH18A1
prerank,Notch binding (GO:0005112),0.3926402145921392,0.945611266882411,0.5214408233276158,0.958990407140457,1.0,7/22,10.40%,NOTCH4;JAG2;DLL4;DNER;KCTD10;ADAM17;DLK2
prerank,histone acetyltransferase activity (GO:0004402),-0.32322814487942997,-0.9436412715990723,0.5049261083743842,0.8950814046797146,1.0,14/30,27.93%,ARRB1;KAT6B;HAT1;EP300;MCM3AP;ATF2;BAZ1A;NAA40;KAT14;TAF9;KAT8;EPC1;NAA50;CREBBP
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4188320336368023,0.9436075771323814,0.5196428571428572,0.9597362722108581,1.0,6/14,18.70%,KCNQ1;KCNH2;KCNJ5;KCNJ3;KCNIP2;KCNA5
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3672783286778718,0.942851351506932,0.515,0.9576319118411408,1.0,6/32,11.05%,KCNQ1;KCNC2;KCNG2;KCNH2;KCNQ3;KCNA4
prerank,metal ion:proton antiporter activity (GO:0051139),0.43901393160113145,0.9423391829244268,0.5282331511839709,0.9549420664012822,1.0,5/13,9.58%,SLC9A5;SLC9A3;LETM1;SLC9A6;SLC9A7
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4481703250733204,0.9420146888673473,0.5447897623400365,0.9517849552227967,1.0,4/12,17.29%,OPN5;GPR52;OPN3;RRH
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.46953398018859405,0.9417604712877188,0.5458015267175572,0.9485635242630106,1.0,5/10,25.08%,CDKN2B;KAT2B;INCA1;CDKN1B;CDKN2C
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.423058578267204,-0.941411827252891,0.5337552742616034,0.895434714926745,1.0,6/10,28.25%,NSD2;SETD5;SETD2;NSD1;SMYD2;SETMAR
prerank,SH2 domain binding (GO:0042169),-0.32296851274289107,-0.9400602481393392,0.5482233502538071,0.8933419457283627,1.0,4/31,3.76%,AFAP1;IRS1;SH3PXD2B;DAG1
prerank,potassium:proton antiporter activity (GO:0015386),0.4609641312388424,0.9400402273586382,0.5397412199630314,0.9488961426293817,1.0,4/10,9.58%,SLC9A5;SLC9A3;SLC9A6;SLC9A7
prerank,Hsp70 protein binding (GO:0030544),0.36564760371808286,0.9367870532547778,0.5534290271132376,0.9531052181125399,1.0,4/31,8.17%,NOD2;CYP2E1;FICD;SACS
prerank,histone acetyltransferase binding (GO:0035035),0.3833593102789236,0.936735416381915,0.5355285961871751,0.9493996009094416,1.0,5/21,11.75%,EPAS1;STAT1;FOXP3;ZBTB7A;HIF1A
prerank,carbohydrate kinase activity (GO:0019200),-0.4199387936822826,-0.9359260362486915,0.5476718403547672,0.8986275661451143,1.0,4/11,17.25%,HK2;GALK1;NAGK;GALK2
prerank,dynactin binding (GO:0034452),-0.4022726431905934,-0.9352324776784391,0.5273972602739726,0.8949561996598173,1.0,5/12,23.96%,SNX6;BICD1;SNX5;BBS4;HTT
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.41895260548138125,0.9340384059227155,0.5459363957597173,0.9520014151246329,1.0,1/15,3.48%,PLA2G4B
prerank,zinc ion binding (GO:0008270),0.2722925210764429,0.9318241992881554,0.6279904306220095,0.9536794461034628,1.0,52/293,13.76%,SHANK3;MYRIP;PDE2A;SORD;GCH1;TNFSF10;KLF7;ARHGEF2;IFIH1;RNF125;BHMT2;PRDM2;SAMHD1;CRIP2;CLIP1;CD4;RPS29;ZDHHC20;KLF4;MSRB2;MSRB3;KAT6A;SHMT2;TIMM13;PDXK;ENPP2;TRIM24;SNRPC;PGGT1B;ZMYND11;KDM4A;HPF1;ZNF205;TIMM10;CTCF;DUSP12;S100A8;GRIN2B;RPS27;PPARG;GTF2B;ADH5;CYLD;LTA4H;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4450780832120966,0.9312080754232257,0.55,0.9514987946257121,1.0,5/12,9.58%,SLC9A5;SLC9A3;LETM1;SLC9A6;SLC9A7
prerank,ribosome binding (GO:0043022),-0.29306521774341426,-0.9301787515838398,0.5821727019498607,0.9024076011918513,1.0,15/46,23.08%,CPEB1;CPEB2;MRPS27;EIF3C;FMR1;SRP72;NCLN;IGHMBP2;EIF2A;YTHDF1;SEC61B;C1QBP;SEC61A2;SRP68;CPEB4
prerank,phospholipase activity (GO:0004620),0.32219206190878275,0.9296882049060987,0.5681492109038737,0.9514216739386283,1.0,8/67,8.87%,PLCB4;PLA2G4B;PNPLA6;PLD4;GDPD1;LIPC;ENPP2;LYPLA1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.37834017659988417,0.9272297795269774,0.540587219343696,0.9538315985143115,1.0,5/25,4.55%,NOS3;CYP2E1;FMO4;FMO2;NOS2
prerank,receptor ligand activity (GO:0048018),0.273246250056117,0.9232740707677441,0.6298472385428907,0.9594812926960392,1.0,21/245,9.51%,KITLG;SEMA3C;SEMA7A;SEMA6A;PDGFB;TGFB2;JAG2;SEMA6B;WNT7A;NPPA;FGF16;SEMA4F;SEMA6D;PTN;TGFB1;TGFA;GREM1;TNFSF11;FAM3D;SEMA4C;PGF
prerank,telomerase RNA binding (GO:0070034),0.3879132713302771,0.9231139487228712,0.5692041522491349,0.9560569883244516,1.0,8/22,20.57%,HNRNPC;DCP2;SNRPB;NHP2;XRN1;NAF1;EXOSC10;PINX1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3136717113387954,-0.9222491738785524,0.5750636132315522,0.9164519149693071,1.0,7/31,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UBE2B;UBE2Q1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2704537156518098,-0.9212348314476093,0.6354515050167224,0.913577295714071,1.0,14/70,16.08%,GXYLT2;B3GALT1;LARGE1;EXT1;MGAT4C;OGT;B3GLCT;B4GALT1;HEXA;CHPF2;CHSY1;CSGALNACT2;POGLUT2;B3GALNT1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.257633852972612,0.9161654443486902,0.6923925027563396,0.9685907204346366,1.0,75/431,15.72%,MFHAS1;ABCC6;INSR;RHOBTB1;MAP4K2;MAP4K3;GCH1;RAB31;STK38;SNRK;GBP7;ACVRL1;PRAG1;GBP4;GBP5;ZAP70;ABCG1;TGM2;SARS2;ABCD4;ARF5;REM2;MTPAP;HSP90AB1;RHOB;PRKACB;RPS6KA5;ATP1A3;ATP1A1;RALB;YARS2;RAP1B;DNM2;PXK;ADSS2;FICD;ARL4A;MARK4;RAB39A;MAP3K6;ARHGEF5;P2RX7;TWF2;TUBB;PDXK;TAP2;MYO1F;HSPA8;RAC1;ABCD1;MAP4K4;EIF2B2;TUBD1;HRAS;ATP5F1A;RAB4A;MMAA;RND1;PANK3;PNPLA8;NOL9;HACL1;STK3;MINK1;MOV10L1;RHOV;PFKL;DYNC1LI1;TBCK;TUBA1A;STK26;TUBB4B;ARL4D;ACVR1;GNL1
prerank,mRNA methyltransferase activity (GO:0008174),0.42951101540694747,0.9156290321856525,0.5773584905660377,0.9660984555142392,1.0,6/12,23.86%,TRMT10C;TRMT61B;CMTR2;CMTR1;METTL3;PCIF1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.39915544708049605,0.9152164294805779,0.5636042402826855,0.9633066326334638,1.0,9/17,32.94%,AK4;CMPK1;NOL9;DTYMK;NME2;CMPK2;AK8;AK1;AK7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3675563511541176,0.9147397532349929,0.5723793677204659,0.960609969284716,1.0,12/28,26.19%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GRID1;GABRA2;GABRG2
prerank,protein heterodimerization activity (GO:0046982),0.27951596288183406,0.9115179935122031,0.6580565805658056,0.9641120534529526,1.0,21/178,11.75%,HIP1;EPAS1;PDGFB;BCL2L1;ZHX3;FZD4;MEF2C;RALGAPA1;ABCG1;IKBKB;ATP1A1;MCL1;SRI;YWHAH;IRAK2;SIM1;CYBB;TPM4;MTTP;UBA3;HIF1A
prerank,semaphorin receptor activity (GO:0017154),-0.3956575492999459,-0.9114522681444387,0.5957446808510638,0.9325754922489573,1.0,2/11,6.77%,PLXNA2;PLXNB2
prerank,chloride channel activity (GO:0005254),0.3192392411483352,0.9111238740221327,0.5890014471780028,0.9612792060530535,1.0,18/59,19.80%,TTYH2;CLCA2;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;CLCN7;GABRG1;CLIC1;CLCC1;PACC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.37111540771297846,-0.9099377061012754,0.5714285714285714,0.9305601743774468,1.0,3/16,13.73%,SLC22A4;SLC5A7;SLC22A2
prerank,steroid hydroxylase activity (GO:0008395),-0.3636495086825725,-0.9089475923427992,0.5616438356164384,0.9276078507823952,1.0,3/16,5.92%,CYP7B1;CYP27A1;CYP1B1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2671900621425239,0.9076399548979109,0.6690307328605201,0.9656480782471738,1.0,52/254,16.82%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;CD40;FOXO1;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;ACTG1;CBS;AXIN2;UBXN1;SMAD5;CASP8;TRIB2;PRKAR2A;MID1;HSPA8;UBOX5;HIF1A;UQCRC1;TNK2;GGN;RPL11;ARRDC1;BCL10;TPI1;PRDX6;RBX1;RNF8;DNAJA1;ELOB;APC;RALA;HERC2;BAG6;YWHAZ;SUMO1
prerank,peptidase activator activity (GO:0016504),0.381568344036643,0.9071834723470489,0.5574614065180102,0.9630369334836398,1.0,5/22,12.21%,CAV1;MAL;PSME2;APH1A;VSIR
prerank,DNA binding (GO:0003677),0.2492926842602693,0.9070531591035984,0.7694704049844237,0.9596626931970018,1.0,90/694,13.70%,LEF1;MECOM;ETS1;FLI1;ERG;EPAS1;APP;KLF12;TRIM16;ZIC3;PPARD;TBX1;TBX3;IMPDH1;RYBP;LRRFIP1;SMARCA2;ARID3B;FOXO1;FOXL2;SOX13;YBX1;MEN1;HMBOX1;KLF2;PRDM2;ZBTB16;IRF2;SAMHD1;FOXF1;HHEX;NTHL1;SNAI2;POGK;MRE11;STAT1;ZCCHC3;NKX2-8;AIM2;MAX;NR1H2;PALB2;IRF5;HINFP;SOX12;BRCA2;KAT6A;JUN;TSHZ2;ELK4;DNA2;FOXP3;PRDM9;ZBTB14;FANCG;SIM1;ARID1A;HMGA1;DEDD2;ZMYND11;OASL;MCM10;BANF1;LIN9;CBFB;MPG;CTCF;NR5A2;TLR8;ZBTB7A;HIF1A;RPS27;GTF2H4;JRK;SOX10;PPARG;TERF1;POLG2;POU2F1;GTF3C5;HMGB2;SLPI;ZBTB33;WDR48;CSRNP3;ORC1;TSNAX;SOX9;RPS15;FAN1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2655844908741308,0.9065996220293806,0.6783625730994152,0.9571468459984004,1.0,54/269,16.82%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;CD40;FOXO1;SMAD7;HSP90AB1;SLC25A5;PRKACB;STAT1;ATXN3;FBXW7;RFFL;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;ACTG1;CBS;AXIN2;UBXN1;SMAD5;CASP8;TRIB2;PRKAR2A;MID1;HSPA8;UBOX5;HIF1A;HGS;UQCRC1;TNK2;GGN;RPL11;ARRDC1;BCL10;TPI1;PRDX6;RBX1;RNF8;DNAJA1;ELOB;APC;RALA;HERC2;BAG6;YWHAZ;SUMO1
prerank,MAP kinase kinase activity (GO:0004708),-0.37013969937511876,-0.9031413019979455,0.5978021978021978,0.9360096697778072,1.0,8/15,23.84%,MAPKAPK3;LRRK2;MAPK14;MAP2K5;MAP2K3;MAP3K9;MAP2K1;MAP2K4
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3585695791293808,0.9028855756340367,0.5881383855024712,0.9617710717876929,1.0,4/28,9.04%,DAB2IP;STAT1;PIDD1;TNFSF11
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3002845707207175,0.9004816082391588,0.60431654676259,0.9636062851753382,1.0,16/74,13.10%,DGKH;NT5C3A;DGKI;DGKE;CHKA;PKM;PGM2L1;PDXK;PIK3C3;PIK3C2A;HK1;IPMK;DGKZ;PIK3CB;PANK3;NOL9
prerank,MAP-kinase scaffold activity (GO:0005078),0.430166718484175,0.8984755658881899,0.579047619047619,0.9645031210398085,1.0,3/11,8.29%,SH3RF1;SPAG9;IQGAP1
prerank,mRNA binding (GO:0003729),-0.22083746900860754,-0.8983097016812761,0.7793103448275862,0.941836979536481,1.0,49/249,16.99%,CELF2;RBMS3;SAMD4A;CPEB1;CPEB2;DDX5;SRRM2;HDLBP;RBMS1;RBPMS2;SRSF5;DCP1A;SNRNP70;CSDC2;AUH;AGO2;YBX3;RBM47;LUC7L3;PCF11;ZC3H12B;XPO5;FXR2;SRRM4;NOVA1;FUBP1;SRSF6;SRSF4;RBM5;RNF20;ACO1;LUC7L2;IGF2BP2;HNRNPR;FMR1;NSRP1;PCBP4;DDX3X;LARP6;EIF2A;RBFOX1;HNRNPA2B1;YTHDF1;TUT1;PABPC4;PABPC4L;G3BP2;FYTTD1;PCBP2
prerank,ATPase activator activity (GO:0001671),-0.34168528958699623,-0.8970391794949389,0.6,0.9395322268754146,1.0,7/20,24.46%,ATP1B3;ATP1B2;TOR1AIP1;DNAJB4;DNAJB2;DNAJC24;AHSA1
prerank,neuropeptide hormone activity (GO:0005184),0.3741357734348553,0.8954720657179729,0.6071428571428571,0.9675453457865885,1.0,3/22,11.15%,NPPA;CALCB;PPY
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.3696762768764109,-0.894837802401394,0.5677966101694916,0.9393836382459737,1.0,1/14,3.68%,DHRS3
prerank,transforming growth factor beta binding (GO:0050431),0.3688968590311894,0.8947729942455104,0.5955631399317406,0.9656785998551141,1.0,5/23,5.38%,ENG;LTBP4;ACVRL1;HYAL2;NRROS
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27386870082914017,0.8944960989766927,0.6726572528883183,0.9626742437142738,1.0,19/173,8.77%,DACH1;ELK3;KLF12;PPARD;TBX3;BCL6B;LRRFIP1;SOX13;PRDM2;ZBTB16;HHEX;SNAI2;ETV6;MAX;INSM1;JUN;ZFP69;FOXP3;ZBTB14
prerank,adenyl nucleotide binding (GO:0030554),-0.3980385221069277,-0.8938754936980922,0.5743243243243243,0.9313219500573305,1.0,3/11,14.13%,SIL1;BAG1;BAG3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3980385221069277,-0.8938754936980922,0.5743243243243243,0.9313219500573305,1.0,3/11,14.13%,SIL1;BAG1;BAG3
prerank,serine-type peptidase activity (GO:0008236),-0.2470629921299046,-0.8915091899711279,0.7093425605536332,0.9315585793025676,1.0,19/96,18.58%,PCSK5;HTRA3;F3;FAP;NAALAD2;MMP2;DPP4;KLK2;RHBDL3;HTRA1;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;GZMM;PCSK6
prerank,acetylation-dependent protein binding (GO:0140033),-0.34403776234670713,-0.8914729063247717,0.6157407407407407,0.9214145932906411,1.0,4/20,9.42%,ZMYND8;PSME4;MLLT3;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),-0.34403776234670713,-0.8914729063247717,0.6157407407407407,0.9214145932906411,1.0,4/20,9.42%,ZMYND8;PSME4;MLLT3;BRD9
prerank,3'-5' exonuclease activity (GO:0008408),0.3264397778251003,0.89059998511345,0.6244274809160305,0.9676150863368496,1.0,14/45,22.12%,CNOT6L;NOCT;MRE11;PAN2;PDE12;CNOT6;TRIR;DIS3L;EXOSC10;REV3L;EXOSC9;POLD1;XRN2;RAD1
prerank,phosphatase binding (GO:0019902),-0.2433718427995808,-0.8885412164865701,0.7237354085603113,0.9231094316075816,1.0,25/105,15.77%,EGFR;SMAD3;MAGI2;MAP3K5;ANAPC5;IKBKE;MAST2;DLG1;SH3RF2;DLG4;PDLIM4;MET;AP3B1;MTMR3;SPRED1;PPP1R3C;CRY2;RCAN3;TRPC4AP;HSP90B1;WNK1;MAPK14;PIK3R1;GTF2F1;NFATC2
prerank,adenyl ribonucleotide binding (GO:0032559),0.25645722072525545,0.8879974766594557,0.734717416378316,0.9699728974514473,1.0,50/291,14.83%,ABCC6;INSR;MAP4K2;PDE2A;RAPGEF2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;ABCG1;MYO6;SARS2;ABCD4;PDE4D;MTPAP;HSP90AB1;RAPGEF4;PRKACB;RPS6KA5;ATP1A3;ATP1A1;YARS2;PXK;FICD;MARK4;MAP3K6;P2RX7;TWF2;PDE4B;PDXK;TAP2;MYO1F;HSPA8;ABCD1;MAP4K4;EIF2B2;ATP5F1A;HMGCR;PANK3;PNPLA8;NOL9;HACL1;STK3;MINK1;MOV10L1;PFKL;TBCK;STK26
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.40793685043209515,-0.8856151279756833,0.6275720164609053,0.9247317822176417,1.0,1/10,0.32%,PRKAG2
prerank,ribonuclease activity (GO:0004540),0.3162588737497657,0.8853118046258946,0.6382978723404256,0.9722549114875028,1.0,18/56,22.32%,SAMHD1;PIWIL1;N4BP1;INTS11;RNASE1;RNASEK;CNOT6;RNASE12;TSNAX;PPP1R8;SND1;EXOG;ENDOG;DICER1;EXOSC10;EXOSC9;RNASE6;EXOSC8
prerank,gamma-tubulin binding (GO:0043015),0.37682309109760775,0.883176439558876,0.5946902654867257,0.9732908322516609,1.0,10/21,23.45%,MARK4;BRCA2;ARHGEF7;CDK5RAP2;PAK1;GIT1;DIXDC1;NDRG1;RAB11FIP5;B9D2
prerank,calcium activated cation channel activity (GO:0005227),-0.3496754676633941,-0.8825653745055003,0.62004662004662,0.926600083096875,1.0,4/17,10.80%,ANO6;KCNMB2;ANO1;TRPM4
prerank,double-stranded DNA binding (GO:0003690),0.2449396687414091,0.8825289710711844,0.8014941302027748,0.9711021476337264,1.0,69/531,12.65%,LEF1;FLI1;ERG;ELK3;KLF12;ZIC3;PPARD;TBX1;TBX3;BCL6B;MEF2C;FOXL2;BACH2;YBX1;MEN1;HMBOX1;KLF2;IRF2;GATA2;SOX7;NTHL1;CREB1;BARHL1;SNAI2;TCF7;MRE11;IRF9;STAT1;ZCCHC3;NKX2-8;KLF4;AIM2;MAX;POU3F4;IRF5;SOX18;NFIC;PHOX2A;SOX12;JUN;TCF12;KLF6;TERF2;ATF6B;ELK4;FOXP3;ZBTB14;KLF13;CEBPD;ZNF32;ZMYND11;FOXQ1;SMAD5;ELF2;ATOH7;PKNOX1;LHX5;NR5A2;ZBTB7A;ZNF250;LHX9;GTF2H4;ONECUT1;SOX10;PPARG;LHX6;TERF1;POLG2;TFEB
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2768437188098686,-0.8816989148805436,0.6479289940828402,0.9235330966246782,1.0,10/49,14.89%,ATP1A2;MPPED2;PXYLP1;PTPN22;LHPP;DUSP10;ACP6;ARMT1;PHOSPHO2;ACP2
prerank,exopeptidase activity (GO:0008238),-0.27996483704131553,-0.8802991248901381,0.6819571865443425,0.9218714254353255,1.0,15/50,22.41%,ANPEP;FAP;NAALAD2;ACE;ENPEP;NPEPPS;DPP4;CTSH;CTSZ;ACE2;ZMPSTE24;CTSA;DPP7;GGH;XPNPEP3
prerank,ankyrin binding (GO:0030506),0.37896309944466156,0.8790264642402702,0.6050420168067226,0.9749961434920623,1.0,1/19,0.79%,SPTBN1
prerank,protein phosphatase activator activity (GO:0072542),0.4069640713436721,0.8790138408696918,0.6018181818181818,0.9715070080582907,1.0,4/13,14.61%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.29752416485084665,0.8788335535148336,0.64822695035461,0.9683809132605563,1.0,3/75,2.22%,ABCC4;SORD;IMPDH1
prerank,general transcription initiation factor binding (GO:0140296),0.35039364538529627,0.8754879438683978,0.6375838926174496,0.972239323219669,1.0,6/25,20.19%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.40827179402287084,0.8753151153278586,0.6222627737226277,0.9691685766790208,1.0,3/13,16.91%,DCT;DDT;IDI1
prerank,DNA secondary structure binding (GO:0000217),0.33689076875975266,0.8751884140444731,0.6343042071197411,0.9660057589982963,1.0,7/31,16.37%,MEF2C;MEN1;HMGA1;RECQL4;HMGB2;MSH2;HMGA2
prerank,SUMO binding (GO:0032183),-0.36614999810805504,-0.874493776390445,0.6341463414634146,0.9295616764746777,1.0,6/13,23.66%,TDG;PML;HABP4;USPL1;UBA2;CASP8AP2
prerank,hexosaminidase activity (GO:0015929),-0.3695696303010916,-0.868198342304055,0.6391304347826087,0.9385180114853655,1.0,4/12,13.75%,CEMIP;CEMIP2;HEXA;NAGA
prerank,retinoic acid receptor binding (GO:0042974),0.3812339283461225,0.8665078970829544,0.6384083044982699,0.9803219796454269,1.0,5/17,17.43%,ACTN4;TACC1;HMGA1;PPARG;ASXL1
prerank,antiporter activity (GO:0015297),0.3666582821536131,0.8662852439777511,0.641156462585034,0.9773082016326198,1.0,4/20,11.80%,ATP1A3;CLCN3;SLC35E4;SLC35C1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3122140717922817,0.8652242008738383,0.6580152671755726,0.9761813562647336,1.0,17/49,23.50%,MINDY1;RNF169;OTUD7A;UBXN1;SHARPIN;MINDY2;UBQLN1;EPS15;TNFAIP3;RAD23A;BAG6;TNIP1;BRCC3;OTUD7B;RAD23B;UBL7;PRPF8
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.39786693473815904,0.8640790275597127,0.6261859582542695,0.9750132784164482,1.0,6/12,21.72%,CDK19;BRD4;CCNK;MAPK1;CDK6;CDK4
prerank,transaminase activity (GO:0008483),-0.3704050721844774,-0.8637446981649132,0.6627358490566038,0.9435998059412264,1.0,3/11,11.57%,ABAT;OAT;GOT1
prerank,ion gated channel activity (GO:0022839),0.3599155022728886,0.8632810968800428,0.6397941680960549,0.973241573056219,1.0,3/24,5.01%,TTYH2;TMEM63B;CLCA2
prerank,N-acyltransferase activity (GO:0016410),0.3377586831166475,0.8629255052775555,0.6417445482866043,0.9706844094867455,1.0,4/32,5.78%,CERS4;TGM2;TLCD3B;GLYAT
prerank,voltage-gated ion channel activity (GO:0005244),-0.3586394687621034,-0.861840688424427,0.6155555555555555,0.942732468758226,1.0,2/14,4.80%,ANO6;PKD2
prerank,Wnt-activated receptor activity (GO:0042813),0.39365337916019627,0.8616557593684727,0.656896551724138,0.9698599235159232,1.0,4/15,8.45%,FZD6;FZD4;TSPAN12;LRP5
prerank,CoA hydrolase activity (GO:0016289),-0.3415915741137275,-0.8614169952122324,0.6355555555555555,0.9386824966280914,1.0,3/16,12.47%,ACOT8;ACOT11;HIBCH
prerank,serine-type endopeptidase activity (GO:0004252),-0.24706301069499037,-0.8611768214778387,0.7866242038216561,0.9343497636546318,1.0,18/80,21.40%,PCSK5;F3;FAP;MMP2;DPP4;KLK2;RHBDL3;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;GZMM;PCSK6;PLAU;CLPP
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.39979767960858725,0.8593676888147971,0.6200716845878136,0.9710857769697282,1.0,2/14,5.09%,SLC1A1;SLC1A2
prerank,single-stranded DNA binding (GO:0003697),-0.23657834009080334,-0.8571904780554296,0.8142857142857143,0.9378150325083703,1.0,31/93,29.86%,SSBP2;TOP1;RBMS1;FBH1;TDP2;RAD51B;RBBP8;FUBP1;REXO4;SMC6;CRY2;NUCKS1;IGHMBP2;ERCC1;PCBP2;DMC1;CDC45;TDP1;MCM3;MCM4;MCM5;HMGB1;MCM9;RAD51AP1;NUP35;HMCES;SETMAR;SPRTN;DHX36;NEIL3;MEIOB
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.33689912587710463,0.8532046874555343,0.6481178396072013,0.9804743999402951,1.0,5/29,10.91%,ACER2;HYAL2;ACER1;PARG;MGAM
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23606703485478903,0.8520630033647912,0.8825396825396825,0.9794358798787873,1.0,73/597,12.39%,LEF1;ETS1;FLI1;ERG;ELK3;KLF12;ZIC3;PPARD;TBX1;TBX3;SOX17;BCL6B;MEF2C;SMARCA2;FOXL2;SOX13;BACH2;YBX1;MEN1;HMBOX1;KLF2;IRF2;HHEX;GATA2;SOX7;CREB1;BARHL1;KLF1;SNAI2;TAL1;TCF7;IRF9;NKX2-8;KLF4;MAX;POU3F4;IRF5;SOX18;NFIC;HINFP;PHOX2A;SOX12;JUN;KCNH2;TCF12;KLF6;ATF6B;ELK4;FOXP3;PRDM9;ZBTB14;CDK5RAP2;KLF13;CEBPD;ZNF32;FOXQ1;MCM10;SMAD5;ELF2;ATOH7;PKNOX1;CDC6;CTCF;LHX5;NR5A2;ZBTB7A;ZNF250;LHX9;ONECUT1;SOX10;PPARG;LHX6;SOX11
prerank,miRNA binding (GO:0035198),-0.2907554725906242,-0.8489720064831907,0.7270408163265306,0.9502235232817884,1.0,9/30,23.77%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;SPOUT1;RBM10
prerank,leucine zipper domain binding (GO:0043522),-0.38098301592645734,-0.8452576188768395,0.6540084388185654,0.9527958858230505,1.0,1/10,0.50%,PAWR
prerank,adrenergic receptor binding (GO:0031690),0.37633368079198887,0.8443008193915715,0.648014440433213,0.9915534812850395,1.0,2/16,4.57%,RAPGEF2;PDE4D
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.32970616151070264,-0.8418988590834919,0.683046683046683,0.954322077978473,1.0,4/18,9.92%,ANXA2;ANXA1;CNN3;TMOD3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.25438245372304635,0.8403339086650038,0.7949367088607595,0.9961253371170476,1.0,33/181,16.20%,LMO2;PPARD;NFKBIA;TBX3;NCOA1;ZFPM1;ACTB;CTNNB1;CREB1;TCF23;TAL1;ACTN4;STAT1;KLF4;TACC1;GTF2I;BUD31;NCOA2;JUN;FOXP3;ARID1A;HSPB1;HIF1A;PPARG;HIPK2;BBS10;BCL10;SP1;HDAC5;DNAJA1;RBL1;TAF4B;TAF4
prerank,exoribonuclease activity (GO:0004532),0.39200724001948445,0.8402356182297638,0.6387900355871886,0.992939097738752,1.0,7/12,32.42%,CNOT6;EXOSC10;EXOSC9;EXOSC8;ZC3H12A;CNOT7;EXOSC3
prerank,acetyltransferase activity (GO:0016407),-0.2920478285114744,-0.8377742088978182,0.7168831168831169,0.9573753060008341,1.0,17/31,33.58%,KAT6B;SAT1;ELP3;NAA80;SPHK1;PAFAH2;EP300;SAT2;NAT8L;DBT;KAT8;NAA50;CREBBP;PAFAH1B3;SMARCE1;ESCO2;ESCO1
prerank,growth factor activity (GO:0008083),0.2866632189025686,0.8367077997763193,0.7227011494252874,0.996638169524972,1.0,7/74,10.71%,PDGFB;JAG2;FGF16;PTN;TGFA;PGF;CNTF
prerank,tau protein binding (GO:0048156),0.3148312573176013,0.8363778314624931,0.7018072289156626,0.9939986447087625,1.0,15/40,22.89%,ACTB;HSP90AB1;FYN;MARK4;PIN1;MARK3;GSK3A;BAG2;BIN1;DYRK1A;DCTN1;BRSK2;SNCA;PRKAA1;LGMN
prerank,chloride channel regulator activity (GO:0017081),0.37701021658043893,0.8353094014082938,0.6605839416058394,0.9928144472200564,1.0,6/14,23.30%,STX1A;SGK1;SGK3;WNK2;VAMP8;STX8
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.37351933784942787,0.8335959291979378,0.6702898550724637,0.992832733643426,1.0,8/14,32.94%,AK4;CMPK1;DTYMK;NME2;CMPK2;AK8;AK1;AK7
prerank,retinoid X receptor binding (GO:0046965),0.3964995142491249,0.832331699898773,0.6575091575091575,0.9918977645056309,1.0,3/11,12.29%,TACC1;HMGA1;PPARG
prerank,G protein-coupled receptor binding (GO:0001664),0.2585708258767342,0.8303848434239097,0.7867360208062418,0.992395625038334,1.0,18/132,11.15%,CXCL12;REEP1;S1PR1;GNAI2;GNAQ;WNT7A;ZNRF3;HOMER2;GNA12;NPPA;INSL3;HOMER1;ARHGEF12;RTP4;UTS2B;CALCB;HSPA8;PPY
prerank,transforming growth factor beta receptor binding (GO:0005160),0.36354965733506145,0.8298249440567764,0.6672473867595818,0.9901892555472503,1.0,6/18,12.41%,ENG;TGFB2;SMAD7;TGFB1;FERMT2;TGFBR2
prerank,filamin binding (GO:0031005),0.3953215496378799,0.8295505638283488,0.6845018450184502,0.9874212978909472,1.0,2/11,4.16%,NEBL;RFLNB
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2878852785537284,-0.827937393453375,0.7291666666666666,0.9716306593887342,1.0,12/28,23.84%,PRKAA2;PRKACA;MAPKAPK3;LRRK2;MAPK14;MAP2K5;MAP2K3;RPS6KB1;TTK;MAP3K9;MAP2K1;MAP2K4
prerank,kinase activator activity (GO:0019209),-0.2815529451632889,-0.8247333452377269,0.7135678391959799,0.9728259014732071,1.0,7/30,15.46%,PRKAG2;GPRC5C;STK11;STRADA;WNK1;WNT11;GPRC5A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3494438693289187,-0.8244257878393049,0.7070484581497798,0.9686442264263088,1.0,2/12,7.25%,CYFIP2;AGO2
prerank,chemokine receptor activity (GO:0004950),0.3363411587784971,0.8217277996146349,0.702020202020202,0.9990840666072692,1.0,5/24,17.38%,CCR7;GPR17;CXCR2;GPR75;CCR2
prerank,protein serine/threonine kinase activity (GO:0004674),0.2364278177268599,0.821337040564021,0.8783482142857143,0.9964695713551893,1.0,75/334,18.81%,PRKCH;BMPR2;MAP4K2;MAP4K3;STK38;PKN3;KALRN;SNRK;ACVRL1;RPS6KA1;MAP3K1;STK10;PRKD2;PRKD1;CDK19;MAP3K8;PRKD3;IKBKB;MAST4;PIKFYVE;PKN1;LIMK2;PAK5;MAPK3;RPS6KA5;PKN2;MARK4;MAP3K6;MARK3;IRAK2;PAK1;EIF2AK4;STK33;BRD4;MAP4K4;STK32C;SLK;GSK3A;PRKCB;SYK;PDIK1L;CCNK;TGFBR2;HIPK2;CSNK2B;RIOK1;STK24;STK3;MINK1;CAMK2B;PIM2;SGK1;HIPK3;VRK1;NEK3;PLK2;GRK6;SGK3;SGK2;ACVR1;MAPK1;CPNE3;TTN;SIK2;MAP3K11;CDK11B;PAK2;PRKCG;TBK1;WNK2;PRKCE;CAMK2G;TRIO;CSNK1G2;CDK6
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3640245513479513,-0.8210633107901917,0.6909871244635193,0.9701576048571124,1.0,7/10,28.88%,HAT1;EP300;ATF2;NAA40;KAT8;NAA50;MSL3
prerank,sodium:proton antiporter activity (GO:0015385),0.3961854033324346,0.8204386888860344,0.6593001841620626,0.9948328390921701,1.0,4/11,9.58%,SLC9A5;SLC9A3;SLC9A6;SLC9A7
prerank,voltage-gated potassium channel activity (GO:0005249),0.27425467166378226,0.8180965581354389,0.7561643835616438,0.9961055508213879,1.0,20/80,19.03%,KCNH8;KCNQ1;KCNC2;KCNG2;KCNK6;KCNH2;KCNN2;KCNN3;KCNQ3;KCNV1;KCNA4;KCNH7;HCN2;KCNF1;KCNJ5;KCNJ3;KCNJ6;KCNIP2;KCNA5;KCNC1
prerank,potassium channel regulator activity (GO:0015459),-0.25678698661484844,-0.8178878312161848,0.7809798270893372,0.9713130365544868,1.0,6/49,6.12%,WNK4;KCNIP3;KCNMB2;ABCC9;DLG1;FLNA
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3398519386779759,0.8167321318519197,0.7048611111111112,0.9952917368429691,1.0,4/19,17.99%,AFAP1L2;GREM1;GAS6;PAK2
prerank,CCR chemokine receptor binding (GO:0048020),0.32382638984110024,0.815809476912378,0.7011686143572621,0.9938565345211184,1.0,6/28,23.84%,NES;CCL1;CCR2;CCL25;CNIH4;NARS1
prerank,deubiquitinase activity (GO:0101005),0.2699289614786261,0.8122501415825975,0.7787114845938375,0.9971202033221518,1.0,24/88,20.66%,USP53;MINDY1;ATXN3;EIF3F;MYSM1;OTUD7A;MINDY2;PAN2;USP18;TNFAIP3;CYLD;COPS5;JOSD2;USP49;USP32;USP25;USP21;BRCC3;USP29;OTUD7B;OTUD4;JOSD1;DESI2;EIF3H
prerank,metallocarboxypeptidase activity (GO:0004181),-0.28888344915908665,-0.8104388009391492,0.7274939172749392,0.9804497251406953,1.0,6/26,15.15%,AEBP1;CPXM1;CPXM2;AGBL1;PEPD;ACE2
prerank,bHLH transcription factor binding (GO:0043425),-0.3140115745799466,-0.8089659194775528,0.7177033492822966,0.9781419271304274,1.0,2/19,1.41%,FHL2;SMAD3
prerank,solute:proton symporter activity (GO:0015295),0.3620427435457915,0.8065381267972387,0.697754749568221,1.0,1.0,1/16,1.25%,SLC39A8
prerank,hydro-lyase activity (GO:0016836),-0.26295000389823286,-0.8056079753485296,0.8105849582172702,0.9791838234341904,1.0,19/41,25.86%,GMDS;HACD4;AUH;ECHDC2;HACD1;ACO1;ECHDC1;PCBD2;ECHDC3;EHHADH;CYP2S1;ECI1;ENO2;HADHA;ENO3;ALAD;UROS;L3HYPDH;ECHS1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.257123616221181,-0.8027733681774841,0.8050847457627118,0.9793121576725888,1.0,8/40,13.67%,DNMT3A;PCMT1;HNMT;NNMT;THUMPD3;ARMT1;COMT;PRMT8
prerank,peptide hormone receptor binding (GO:0051428),-0.3549223947339931,-0.8023762633528291,0.7207792207792207,0.9752878553687718,1.0,7/11,51.30%,PTHLH;VIP;GNRH1;UCN2;GPHB5;GHRH;PSMC5
prerank,histone deacetylase activity (GO:0004407),-0.31503201738729125,-0.8022673254676704,0.7704545454545455,0.9708736777143279,1.0,3/19,6.89%,HDAC4;MIER3;SIRT3
prerank,sodium channel activity (GO:0005272),-0.2658397407759229,-0.8007060136443307,0.7937853107344632,0.9689411834839824,1.0,3/37,4.82%,SCN7A;PKD2;CACNA1G
prerank,phosphatase activity (GO:0016791),0.270595231089242,0.7992542526569424,0.7666195190947667,1.0,1.0,17/73,17.33%,PTPRJ;PTPMT1;DUSP23;DUSP3;PLPP6;NOCT;OCRL;PPP1CB;ACP4;DUSP12;ENOPH1;DUSP16;LPIN3;DUSP8;PLPPR4;MINPP1;PLPP2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.26858147049705655,-0.7951245109147019,0.7994791666666666,0.9735003187469281,1.0,15/34,29.52%,SMYD3;EHMT2;SETD7;SETD4;EEF2KMT;KMT5B;EZH2;SETD2;SETD6;KMT5A;EEF1AKMT2;SMYD2;TTLL12;METTL21C;ANTKMT
prerank,chemokine activity (GO:0008009),0.3134347840989991,0.7949585331706231,0.7362270450751253,1.0,1.0,1/31,1.28%,CXCL12
prerank,GABA-A receptor activity (GO:0004890),0.3403964009931676,0.7923172361438156,0.712280701754386,1.0,1.0,8/18,26.19%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36723763817331745,-0.7916458968820242,0.7256637168141593,0.9744079247898154,1.0,1/10,6.87%,LACC1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.301271023655127,0.7911882037935635,0.7774244833068362,1.0,1.0,5/38,9.33%,SHANK3;CARD10;SPAG9;SORBS1;DEDD2
prerank,voltage-gated cation channel activity (GO:0022843),0.25771472321591504,0.7893105770692881,0.8450134770889488,1.0,1.0,15/97,13.04%,CACNA1A;KCNH8;KCNQ1;KCNC2;CACHD1;KCNG2;GRIN3B;KCNH2;KCNQ3;KCNV1;KCNA4;GRIN2B;KCNH7;HCN2;KCNF1
prerank,DNA-binding transcription factor binding (GO:0140297),0.23748474217042148,0.7886234954498977,0.8962962962962963,1.0,1.0,39/189,18.25%,LMO2;PPARD;TBX3;MEF2C;ZFPM1;HDAC9;HDAC7;PTMA;HHEX;CTNNB1;CREB1;TCF23;TAL1;CRTC1;STAT1;KLF4;GTF2I;TLE4;JUN;TCF12;HSPB1;TLE1;ZBTB7A;PPARG;EIF4E;HIPK2;BBS10;ZBTB17;SP1;HDAC5;CTBP1;USF1;RBL1;HCFC1;YWHAZ;LYAR;MEF2D;SIN3A;PSMD9
prerank,chemoattractant activity (GO:0042056),0.3195663635682188,0.7878771830195306,0.7213375796178344,1.0,1.0,1/26,0.85%,PDGFB
prerank,potassium channel activity (GO:0005267),0.2611067831125684,0.7868096559378611,0.8526603001364257,1.0,1.0,16/89,13.54%,KCNH8;KCNQ1;KCNC2;KCNG2;KCNK6;KCNH2;KCNN2;KCNQ3;KCNV1;KCNA4;KCNH7;HCN2;KCNF1;GRIK5;GRIK2;GRIK1
prerank,ATP binding (GO:0005524),0.22886897853735977,0.7857097941692773,0.9211764705882353,1.0,1.0,43/266,14.83%,ABCC6;INSR;MAP4K2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;ABCG1;SARS2;ABCD4;MTPAP;HSP90AB1;PRKACB;RPS6KA5;ATP1A3;ATP1A1;YARS2;PXK;FICD;MARK4;MAP3K6;P2RX7;TWF2;PDXK;TAP2;MYO1F;HSPA8;ABCD1;MAP4K4;EIF2B2;ATP5F1A;PANK3;PNPLA8;NOL9;HACL1;STK3;MINK1;MOV10L1;PFKL;TBCK;STK26
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39116586835842104,0.7846849998144246,0.7092198581560284,1.0,1.0,3/10,13.59%,NAA60;NAA16;NAA11
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.32265935621842823,-0.7818092213679736,0.7674418604651163,0.9863572966671764,1.0,2/15,13.52%,CCR9;CMKLR1
prerank,chemokine receptor binding (GO:0042379),0.2993001289878177,0.7789024984504775,0.768,1.0,1.0,1/35,1.28%,CXCL12
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3646206963638728,0.7744989267971907,0.7218181818181818,1.0,1.0,1/12,2.75%,NOD1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.33481966320952805,-0.7733857672139094,0.7630434782608696,0.9953314380400025,1.0,4/12,23.79%,BACE2;PSEN1;HM13;SPPL2B
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.37921317302863733,0.7721496494856926,0.7354085603112841,1.0,1.0,1/10,2.15%,CD200
prerank,RNA binding (GO:0003723),0.2089159233221723,0.7713520443139233,0.9979859013091642,1.0,1.0,308/1321,21.82%,TFRC;SORBS2;RBM20;SPTBN1;SYNE1;MACF1;NANOS3;NOVA2;QKI;FASN;PRPF38B;AGFG1;TRIM25;FLNB;LRRFIP1;MAP4;YBX1;IFIH1;NPM3;MSI2;TMSB4X;SELENOH;ADAR;GRB2;SAMHD1;SARS2;SARS1;NANOS2;NOCT;MRPL12;PIWIL1;MTPAP;HSP90AB1;EFTUD2;SLC25A5;RPL38;TLR3;EIF4H;NOL4;MRPL13;RPL13;NANOS1;ACTN4;PPIA;MAK16;GPATCH1;ZCCHC3;PIN4;MRPL10;PTBP3;RPL36A;EDC3;STXBP1;RPL3;ZNFX1;PKN2;ABT1;RNPS1;ACTN1;YARS2;N4BP1;TLR7;BST2;NPM2;RPSA;SRP14;RPL27;TIAL1;MRPL14;NOP16;PKM;SNU13;JUN;TDRD7;EIF3E;PDAP1;TWF2;DHX37;MSN;DNA2;RPS7;RPL9;CSTF2;SLC3A2;RPL18;CCT3;SNRPF;GTPBP1;SNRPC;HNRNPC;PDCD11;LRRC47;RBM19;OASL;EIF2AK4;SCG3;MAGOHB;RPL13A;EIF3D;EIF5A;GFM1;ZCRB1;HSPA8;HELZ2;ZFP36L1;TASOR;WDR36;DCP2;NCBP2;TLR8;HSPB1;RPS11;LARP1B;MPHOSPH10;RBPMS;UTP3;GPKOW;R3HDM1;PWP2;ATP5F1A;RPL8;RPS27;TRMT10C;NOL10;RBM45;ASCC3;RPL19;NELFCD;DXO;MRPL54;RPS9;RFTN1;MRPL28;EIF4E;MRPL20;RPP38;SNRPB;PUM3;HMGB2;DCP1B;SLPI;ADAD1;RO60;RPL11;EDF1;KMT2C;CCDC137;DHX32;ZC3H11A;RBM42;RPL22L1;TSNAX;LTA4H;RPS15;FSCN1;ZC3H7A;RPL37;PSTK;FAM98A;EIF3G;SRBD1;EIF3B;METAP2;STIP1;PPP1R8;RPS28;MOV10L1;ESF1;SERBP1;RTRAF;UTP11;DYNC1LI1;G3BP1;YTHDC2;ELAVL1;EIF3L;IREB2;ZBED4;COA6;PNO1;RPS10;TUBB4B;FBRSL1;RPS25;ZC3H13;TNS1;DDX55;NOL7;NHP2;LBR;CS;EIF1B;RALYL;SND1;TSN;NOC4L;UBTF;ZC3HAV1;YLPM1;MCRS1;RCC2;EIF4A1;MRPL40;DDX18;MRPL44;PRPF40A;FRG1;AQR;RPL37A;CPNE3;MRPL9;UBAP2;ISG20L2;YWHAZ;MRPS9;FAU;RPP21;MYH10;CSTB;SUMO1;NTPCR;UNC50;LYAR;NOL8;RBFOX3;ALKBH8;HSPE1;ISY1;MSI1;NUDT1;CDK11B;SAMSN1;HSPA9;HLTF;DDX11;RANGAP1;SF3A2;XRN1;DEK;RPL15;NAF1;DICER1;RBM38;CCDC9B;SNRPD2;LSM4;EXOSC10;RRP12;TRMT2A;RBMS2;S100A16;PUF60;MRPL16;NOC2L;SUCLG1;MRPL23;RPL17;RPL23;CMSS1;CDC5L;HNRNPLL;OTUD4;CAPRIN1;ARL6IP4;RPL34;MECP2;MRPL39;WDR75;RBM8A;DAZL;GRWD1;RPS18;NUDT16;EXOSC9;XPOT;ZFP36L2;RTCB;ASS1;HNRNPM;JMJD6;PINX1;APEH;THUMPD1;GTF2E2;EIF3H;XRN2;GCN1;MRPL21;SUB1;RADX;RBM15;RPL21;HSD17B10;NSUN6;CNOT4;NVL;RPP30;PEF1;PRKRIP1;DDX54;RDX;RPS4X;ELAVL2;NCBP1;METTL3;LRPPRC;NUP42;TXN
prerank,carboxypeptidase activity (GO:0004180),-0.25599103498565684,-0.7706052834970432,0.8549618320610687,0.9948524132605466,1.0,9/35,15.15%,AEBP1;SCPEP1;NAALAD2;CPXM1;CPXM2;AGBL1;PEPD;CTSZ;ACE2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.33673097097585253,0.7694672828450582,0.7335526315789473,1.0,1.0,3/16,10.75%,NTHL1;CD38;SMUG1
prerank,death receptor binding (GO:0005123),0.3497428394166755,0.7688964337523414,0.7408759124087592,1.0,1.0,2/15,8.47%,DAB2IP;PIDD1
prerank,syntaxin binding (GO:0019905),0.26659592898619733,0.7677104264508816,0.8214804063860668,1.0,1.0,10/61,15.54%,CACNA1A;UNC13B;SYPL1;STXBP1;RAB11A;SYNPR;SNAP29;CPLX1;SYPL2;SCFD2
prerank,C-C chemokine receptor activity (GO:0016493),0.32099770494545304,0.7673088890991259,0.7607573149741824,1.0,1.0,4/21,17.38%,CCR7;CXCR2;GPR75;CCR2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2632182886286552,0.7671263148039466,0.8359046283309958,1.0,1.0,11/69,12.78%,CERS4;ZDHHC14;ZDHHC9;GLYAT;ZDHHC20;KAT6A;AWAT2;ZDHHC18;LPCAT3;GTF2B;NAA16
prerank,ADP binding (GO:0043531),-0.27885015260438545,-0.7666049376772957,0.8280871670702179,0.9964365199420753,1.0,2/25,4.08%,PRKAG2;ME1
prerank,phosphatase activator activity (GO:0019211),0.35048393525682175,0.7650427840806442,0.744954128440367,1.0,1.0,4/14,14.61%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.33355496909542903,-0.7647923042234456,0.755939524838013,0.994650274963738,1.0,6/11,23.35%,CASP12;CASP3;CASP6;PYCARD;CASP4;CASP9
prerank,Tat protein binding (GO:0030957),-0.34924918398032945,-0.7645724345300341,0.7538461538461538,0.9904344721743803,1.0,2/10,8.31%,MDFIC;SMARCB1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.34935196719565276,0.7621767122755229,0.7605633802816901,1.0,1.0,1/15,1.25%,SLC39A8
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.33448078453102015,-0.7605255610495399,0.76,0.9918535222343843,1.0,2/11,11.40%,AKR1B1;AKR1B10
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.26041793737112684,0.7600778192637562,0.849645390070922,1.0,1.0,14/73,17.03%,HCRTR1;APLNR;CALCRL;OXTR;SORCS1;NLRP6;HCRTR2;NPR1;ADCYAP1R1;CYSLTR1;RXFP2;RXFP3;OPRD1;GLP1R
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.33894343437584007,-0.7590541163629939,0.7685774946921444,0.9893211438814171,1.0,3/10,8.56%,FAP;NAALAD2;DPP4
prerank,protein kinase activator activity (GO:0030295),-0.22608663558521608,-0.7586540782207041,0.9017341040462428,0.9853892452363795,1.0,12/60,16.31%,PRKAG2;FAM20A;GPRC5C;IGF2;CAB39L;STK11;STRADA;WNK1;WNT11;DDX3X;GPRC5A;ERCC6
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.32180635629334087,-0.7586329126182697,0.7572383073496659,0.9809819227037943,1.0,1/12,1.07%,B3GALT1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3509657746020483,0.7567758777718004,0.7660377358490567,1.0,1.0,6/12,28.65%,STAT1;TNFSF11;TRAF3;TRAF6;TRAF1;TRAF2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25239860221440613,-0.7546874442781498,0.8545454545454545,0.9824000630089001,1.0,6/34,14.53%,FAM20A;CCNT2;IGF2;CAB39L;STRADA;DDX3X
prerank,3'-5' DNA helicase activity (GO:0043138),0.3385043251832691,0.7495525479580549,0.7589285714285714,1.0,1.0,3/16,11.97%,NAV2;RECQL4;ASCC3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3309745804947935,0.7473473139403897,0.7567567567567568,1.0,1.0,6/16,18.87%,INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3185661135895374,-0.7448611448267674,0.8051948051948052,0.991675168515583,1.0,3/13,10.63%,THUMPD3;TRMT10B;TRMT1L
prerank,glycine binding (GO:0016594),0.3580487272265305,0.7447124940178622,0.7574692442882249,1.0,1.0,5/11,25.22%,GRIN3B;GRIN2B;GLRA2;GRIN1;GLRA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3186118160744267,-0.7434110132510341,0.7835051546391752,0.9890937452650457,1.0,5/12,16.59%,AOX1;SDHB;FXN;CISD2;FDX1
prerank,ribosomal small subunit binding (GO:0043024),0.3218285271676568,0.7432252670620373,0.7960644007155635,1.0,1.0,10/17,27.61%,EIF4H;MTIF3;EIF1B;ABCE1;EIF4B;PIM1;ERAL1;PTCD3;EIF1;DHX29
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.32407245211607316,-0.7405196306272153,0.811529933481153,0.9887360650149718,1.0,2/11,14.25%,SLC5A3;SLC2A10
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.276261821904159,0.7402925543149088,0.8429003021148036,1.0,1.0,12/42,23.27%,CCNY;CDKN2B;CCNI;CCND3;CCNK;CCNT1;CCNL2;KAT2B;CCNJL;CCNQ;INCA1;CDKN1B
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.27172893986643604,-0.7384683655666902,0.8501228501228502,0.9827288475740497,1.0,9/21,26.60%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK9;CDK10
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.27172893986643604,-0.7384683655666902,0.8501228501228502,0.9827288475740497,1.0,9/21,26.60%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK9;CDK10
prerank,endopeptidase regulator activity (GO:0061135),-0.24598819647584758,-0.7362607874777835,0.8846153846153846,0.9813176144970734,1.0,5/40,10.86%,TFPI;ITIH2;SERPIND1;RENBP;PSME3
prerank,thioesterase binding (GO:0031996),0.34714126222806263,0.7358868770112774,0.7760910815939279,1.0,1.0,6/11,28.65%,RAC1;TRAF3;TRAF6;TRAF1;CDC42;TRAF2
prerank,nucleosomal DNA binding (GO:0031492),-0.2693715469112722,-0.7349511617801564,0.8492462311557789,0.9787032594197175,1.0,6/21,18.79%,SMARCC2;SMARCB1;CHD4;MBD2;RBBP4;SMARCC1
prerank,5'-nucleotidase activity (GO:0008253),0.33825349083888173,0.7308735234026922,0.7731239092495636,1.0,1.0,2/13,5.27%,NT5C3A;NT5C2
prerank,nuclease activity (GO:0004518),0.25833952085281586,0.7305835614200525,0.862015503875969,1.0,1.0,13/52,18.25%,SAMHD1;NTHL1;MRE11;N4BP1;DNA2;DFFB;PDE12;RNASE1;RNASE12;SND1;ISG20L2;EXOG;ENDOG
prerank,histone methyltransferase activity (GO:0042054),-0.25255745822490927,-0.7293681244091021,0.8693333333333333,0.9817100155818607,1.0,13/32,27.48%,SMYD3;EHMT2;SETD7;PRMT5;PRMT8;KMT5B;EED;EZH2;SETD2;KMT5A;SMYD2;PRMT2;TTLL12
prerank,inward rectifier potassium channel activity (GO:0005242),0.3011899146448076,0.7272339905305567,0.8204283360790774,1.0,1.0,7/24,18.27%,KCNK6;KCNH2;KCNN2;KCNN3;KCNJ5;KCNJ3;KCNJ6
prerank,nucleotidase activity (GO:0008252),0.32179613843257304,0.7257302273544353,0.7912457912457912,1.0,1.0,2/15,5.27%,NT5C3A;NT5C2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.35167558281037153,0.7237920226944276,0.80990099009901,1.0,1.0,4/11,24.95%,TERF2;TERF1;RPA1;NABP2
prerank,receptor antagonist activity (GO:0048019),-0.27710423656763655,-0.7204819700497962,0.8048192771084337,0.9883656310216092,1.0,1/17,1.66%,DKK3
prerank,sequence-specific mRNA binding (GO:1990825),-0.3342596936371065,-0.7192882078399642,0.826271186440678,0.9855284017945432,1.0,3/10,22.09%,FMR1;LARP6;RBM24
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.34225697512709646,0.7185611496233881,0.7889733840304183,1.0,1.0,7/12,26.19%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,ubiquitin binding (GO:0043130),-0.2080094072691468,-0.7178201433988474,0.9649122807017544,0.9830597783625794,1.0,23/73,24.54%,SMAD3;TSG101;PRKN;RNF31;AUP1;OTULINL;SIRT2;IKBKG;DNAJB2;MVB12A;TOP2A;USP16;USPL1;NBR1;USP13;ASCC2;OTUB1;UBAP1L;NEDD4;RAE1;TOM1L1;UCHL3;UBXN2A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.3055709193478183,-0.7154657929743513,0.785234899328859,0.9815477055881168,1.0,3/13,15.07%,GABRA3;GLRB;GABRE
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2857484208615012,-0.7118738908886681,0.8294930875576036,0.9815785937269303,1.0,12/17,45.49%,ACOT8;ACOT11;PLA2G6;THEM4;ACOT1;ACOT13;ACOT12;ACOT2;ACAA2;BAAT;ACOT4;ACOT7
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3015601764152945,0.7093730393855885,0.7986348122866894,1.0,1.0,4/21,14.09%,WASF2;KCNQ1;AKAP9;AKAP6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3157176655602705,0.7071998149665739,0.8043087971274686,1.0,1.0,2/16,17.42%,PIR;HGD
prerank,DNA replication origin binding (GO:0003688),0.29173817578891703,0.7034192844256285,0.8454706927175843,1.0,1.0,6/23,20.88%,MCM10;CDC6;ORC1;DDX11;GRWD1;POLA1
prerank,chloride channel inhibitor activity (GO:0019869),0.3411180417936281,0.7004597421693806,0.8201160541586073,1.0,1.0,1/10,2.65%,STX1A
prerank,P-type ion transporter activity (GO:0015662),0.32646728863732893,0.697629418825155,0.781190019193858,1.0,1.0,2/12,6.22%,ATP2C1;ATP2B1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.2932804977984553,0.6961402226282151,0.8401360544217688,1.0,1.0,2/22,3.63%,ATP2C1;ATP6V0A1
prerank,glutathione transferase activity (GO:0004364),0.29027908416670156,0.6961005590600777,0.8581436077057794,1.0,1.0,4/23,9.75%,MGST2;GSTA4;HPGDS;GSTK1
prerank,DNA polymerase binding (GO:0070182),0.3006799549374758,0.6947863341985742,0.84375,1.0,1.0,7/18,24.95%,HSP90AB1;ACD;POLG2;LONP1;PTGES3;SMARCA4;NABP2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24889517236927264,0.6931659283286374,0.9021739130434783,1.0,1.0,5/54,5.14%,ACER2;HDAC9;TGM2;HINT1;ACER1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.24121348908327284,-0.6908877560215061,0.9072681704260651,0.999994246131443,1.0,8/27,26.47%,POLR2A;TENT2;POLR3K;POLR1C;POLR2L;POLR1D;POLR2I;POLR3A
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.24038710014376702,-0.6907297384258118,0.9142156862745098,0.9959305249406634,1.0,8/27,26.47%,POLR2A;POLR3K;POLR1C;PRIMPOL;POLR2L;POLR1D;POLR2I;POLR3A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.278406742914057,0.6907060326447461,0.8766891891891891,1.0,1.0,15/29,28.05%,PKIG;CDKN2B;PRKAR2B;PRKAR2A;HSPB1;RPTOR;KAT2B;INCA1;CDKN1B;SFN;CDKN2C;PRKAR1A;INKA2;PRKAR1B;INKA1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.33651493139642685,0.6892203750840599,0.8342059336823735,1.0,1.0,3/11,13.59%,NAA60;NAA16;NAA11
prerank,GABA receptor activity (GO:0016917),0.2859044366617719,0.6888014829360147,0.865979381443299,1.0,1.0,9/21,26.19%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABBR2;GABRA2;GABRG2
prerank,damaged DNA binding (GO:0003684),-0.21608004461871516,-0.6870322051052401,0.9428571428571428,0.9955595319601799,1.0,23/44,36.86%,RBBP8;TDG;DDB2;SMC6;CRY2;XRCC1;EP300;ERCC1;SDE2;CUL4B;NBN;HMGB1;CREBBP;ERCC2;NEIL3;APEX1;FEN1;RAD18;AUNIP;ERCC5;UNG;DCLRE1A;POLQ
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.288774807091653,-0.6862166083933395,0.8912037037037037,0.9921781969790682,1.0,4/14,16.52%,SDHB;ACO1;RSAD1;NDUFS1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.33745281069309674,0.6845908972770088,0.8281535648994516,1.0,1.0,2/10,13.70%,ANKRD13A;FAN1
prerank,ligand-gated anion channel activity (GO:0099095),0.3025792596718477,0.6812809507812202,0.8543516873889876,1.0,1.0,9/17,26.19%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GABRA2;GLRA1;GABRG2
prerank,tau-protein kinase activity (GO:0050321),-0.262046832464568,-0.6809336405306129,0.9012048192771084,0.9930105387580166,1.0,2/20,6.10%,ROCK2;MARK1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.33667701726888966,0.6787682788616629,0.8407407407407408,1.0,1.0,3/10,13.57%,B4GALT5;B3GALT4;B3GALT2
prerank,cysteine-type peptidase activity (GO:0008234),-0.19885464671903455,-0.6781960762577064,0.9818840579710145,0.9915421924730492,1.0,26/73,25.79%,USP11;USP24;CTSL;USP40;USP2;ATG4A;CTSH;OTULINL;USP42;CASP3;CTSZ;USP9X;USP50;CASP6;SFRP1;USP16;USP13;OTULIN;USP15;GGH;CASP4;CASP9;USP10;USP20;USP37;USP36
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.33140120403945617,0.6779538315934048,0.8223443223443223,1.0,1.0,3/10,12.71%,CYBB;NCF4;NOX3
prerank,C-C chemokine binding (GO:0019957),0.27600093421854277,0.6700072975000535,0.8700173310225303,1.0,1.0,2/22,8.27%,CCR7;CXCR2
prerank,thyroid hormone receptor binding (GO:0046966),-0.23057913689725856,-0.6683019110567643,0.956989247311828,0.9958992018091699,1.0,11/28,27.16%,HMGN3;BRD8;TRIP12;MED30;NCOR1;MED4;NSD1;GTF2H1;MED24;MED16;PRMT2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.32264692701011155,0.6661972019117455,0.850909090909091,1.0,1.0,1/11,7.23%,CHRNB1
prerank,sodium channel regulator activity (GO:0017080),-0.2200847522161619,-0.6658353811311772,0.9517426273458445,0.9939418034436038,1.0,3/37,3.97%,PTPN3;SNTA1;CAMK2D
prerank,regulatory RNA binding (GO:0061980),-0.21736637122230212,-0.66392108087455,0.9522546419098143,0.991464406652845,1.0,10/38,21.26%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;PIWIL2;TARBP2;SPOUT1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.29740558057148847,-0.6637490168490617,0.8543478260869565,0.9875958206328265,1.0,5/10,23.35%,CASP12;CASP3;CASP6;CASP4;CASP9
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.1923843788548649,-0.6627378859375149,0.9824561403508771,0.9844794915831486,1.0,34/78,32.40%,USP11;USP24;CTSL;USP40;CASP12;USP2;CTSH;USP42;CASP3;CAPN1;CTSZ;USP9X;CASP6;SFRP1;USP16;USP13;PYCARD;USP15;CASP4;CASP9;CAPN15;USP10;USP20;USP37;USP36;GPAA1;USP9Y;USP47;USP1;USP33;CASP2;ESPL1;CAPN11;UCHL1
prerank,E-box binding (GO:0070888),0.26099547136628853,0.661163708360765,0.8963815789473685,1.0,1.0,5/34,12.29%,SNAI2;TAL1;MAX;CIART;PPARG
prerank,hormone activity (GO:0005179),-0.2020529768475414,-0.6575258236682013,0.9556213017751479,0.9848941836111427,1.0,1/54,0.34%,IGF1
prerank,RNA cap binding (GO:0000339),0.2971007251285032,0.6533283794952401,0.8851590106007067,1.0,1.0,7/16,22.90%,CYFIP1;EIF3D;NCBP2;EIF4E;EIF4A1;NCBP1;DCPS
prerank,calcium-activated potassium channel activity (GO:0015269),0.30626379248969104,0.6484781810164905,0.8652482269503546,1.0,1.0,2/11,8.52%,KCNN2;KCNN3
prerank,rRNA binding (GO:0019843),-0.2090063334908878,-0.644882466353235,0.9715909090909091,0.990770985759023,1.0,13/42,26.26%,MRPS27;MTERF4;PPAN;EMG1;RCC1L;CIRBP;UTP23;MRPL18;MRPS6;FASTKD2;RPS5;ERI1;NOP53
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3098811947882572,0.64484404135042,0.8665447897623401,1.0,1.0,6/11,22.90%,NUDT3;DCP2;NUDT1;NUDT10;NUDT16;DCPS
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.23964682768837525,-0.6443312606497923,0.927461139896373,0.9872535749681439,1.0,8/22,21.12%,IKBKE;ZRANB3;ZBTB1;IKBKG;OPTN;ATRIP;TAB3;WDR81
prerank,mannose binding (GO:0005537),-0.273695282876776,-0.6436275108331285,0.8955555555555555,0.9839029093429779,1.0,9/12,51.92%,LMAN1;LMAN2L;COLEC11;LMAN2;CLEC4D;ACR;CLEC6A;CD207;LMAN1L
prerank,GDP binding (GO:0019003),-0.18899615968480532,-0.6419237998979953,0.996996996996997,0.9813130979792679,1.0,18/63,24.78%,ARL3;TRIM23;RAB21;MRAS;RASL12;MIEF1;RHEB;RAB29;RIT1;GNAI3;RAB11B;RAB22A;RAB14;RERG;RAP2C;RAB9A;RAP2A;RASEF
prerank,kinesin binding (GO:0019894),0.2646060758298677,0.6386957502943714,0.9246575342465754,1.0,1.0,6/27,17.59%,ACTB;CLSTN1;SPAG9;AP1AR;AP1G1;ARHGEF10
prerank,beta-tubulin binding (GO:0048487),0.25035965296626816,0.6384219152539269,0.9109243697478991,1.0,1.0,2/31,3.25%,TTLL7;FGF13
prerank,magnesium ion binding (GO:0000287),0.19975775467514564,0.6375311250672336,0.9853333333333333,1.0,1.0,36/135,22.60%,PDE2A;STK38;SNRK;HPRT1;NT5C3A;MTPAP;PRKACB;IDH3A;MAP3K6;PDXK;HPGDS;NUDT3;DXO;CERK;HACL1;STK3;FAN1;XYLT2;MOV10L1;PDCD6;STK26;MSH2;NLRC4;SIK2;TPPP;CIB2;ADPRS;PGP;MAP2K7;NUDT16;BRSK2;MAST1;SIK3;CDC42BPA;SNCA;PAPOLA
prerank,four-way junction DNA binding (GO:0000400),0.275622832370776,0.6373723378626495,0.8848920863309353,1.0,1.0,3/17,16.03%,MEN1;HMGB2;MSH2
prerank,NADP binding (GO:0050661),0.2464927207709534,0.635119285538388,0.9229508196721311,1.0,1.0,3/32,5.80%,NOS3;NOS2;CAT
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30003202752928765,0.6330855602502901,0.8740740740740741,1.0,1.0,4/12,26.33%,SLC25A5;SLC35B3;SLC25A23;LRRC8A
prerank,deoxyribonuclease activity (GO:0004536),0.28909947979676,0.6318943461554215,0.8934707903780069,1.0,1.0,2/14,8.78%,MRE11;DFFB
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.25231760152236016,-0.6302905602715098,0.9256756756756757,0.9856012373526373,1.0,5/14,21.73%,NOX4;CYBA;MICAL1;KMO;NOX1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.2920762902936394,-0.6285381314422603,0.9182795698924732,0.983017298754405,1.0,2/10,15.07%,GABRA3;GABRE
prerank,neuropeptide binding (GO:0042923),0.2728274764415702,0.627616709728179,0.9092526690391459,1.0,1.0,4/18,25.45%,OPRD1;SSTR1;OPRM1;GPR149
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.2737772642876424,-0.6193455322958579,0.9187935034802784,0.9849165997837245,1.0,3/11,14.72%,PRMT5;PRMT8;PRMT9
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.2725114184554691,-0.6188077541617172,0.9148936170212766,0.9813296287361117,1.0,3/11,25.15%,SLC25A24;SLC35B2;SLC25A42
prerank,phospholipase A2 activity (GO:0004623),0.24840018009860695,0.6175527837456166,0.9299363057324841,1.0,1.0,3/26,14.45%,PLA2G4B;PNPLA8;PRDX6
prerank,ferrous iron binding (GO:0008198),-0.2263435742867587,-0.6155968425456861,0.9569160997732427,0.9793614875210029,1.0,4/21,12.97%,EGLN3;FXN;PHYH;ALKBH1
prerank,snoRNA binding (GO:0030515),-0.2131842966475081,-0.612999703367903,0.9691516709511568,0.9771001361933888,1.0,5/30,17.24%,NUDT4;NOP14;XRCC5;GAR1;NOP56
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.25599487095724516,0.6083223690501777,0.9402730375426621,1.0,1.0,3/21,13.08%,CHRNB1;P2RX7;GRIK2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2717479260374164,0.6037118525558214,0.9194139194139194,1.0,1.0,4/13,24.51%,DNA2;FAN1;DICER1;GEN1
prerank,exonuclease activity (GO:0004527),0.21877965609237887,0.6006789489081656,0.9798761609907121,1.0,1.0,16/46,22.32%,MRE11;ENPP2;PDE12;CNOT6;DXO;FAN1;TRIR;ISG20L2;EXOG;EXOSC10;REV3L;EXOSC9;XRN2;DCLRE1C;RAD1;EXOSC8
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2949159452100385,0.5986507261845333,0.9037037037037037,1.0,1.0,2/10,13.70%,ANKRD13A;FAN1
prerank,tRNA binding (GO:0000049),-0.19649198614885607,-0.5960698334688428,0.9622641509433962,0.9829760160989621,1.0,20/43,30.97%,TRMT9B;DALRD3;MRPS27;TRMT10B;NSUN2;ALKBH1;ELP5;IGHMBP2;EIF2A;RPUSD4;DARS2;TYW5;FARS2;TRNAU1AP;AIMP1;SEPSECS;PTCD1;KARS1;CTU1;TERT
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.23247734527574596,0.5954430043895136,0.9616666666666667,1.0,1.0,7/34,22.19%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.23247734527574596,0.5954430043895136,0.9616666666666667,1.0,1.0,7/34,22.19%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.26300129917283643,0.5918915535595468,0.9195804195804196,1.0,1.0,2/15,7.01%,SNX3;PLEKHA5
prerank,single-stranded RNA binding (GO:0003727),0.2150681701759325,0.5915517321408271,0.9712918660287081,1.0,1.0,15/43,27.24%,IFIH1;EIF4H;TLR7;SNRPC;TLR8;AQR;DDX11;EXOSC10;JMJD6;EIF4B;LONP1;ADARB2;DDX60;AGO1;HNRNPF
prerank,ribonuclease P RNA binding (GO:0033204),0.2891840835629258,0.590392512647127,0.8914285714285715,1.0,1.0,3/10,21.39%,RPP38;RPP21;RPP30
prerank,U6 snRNA binding (GO:0017070),0.2683047926040213,0.5843836427312168,0.9379432624113475,1.0,1.0,5/14,25.52%,EIF5A;PRPF4;LSM4;PRPF8;SART3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19572166663896745,0.5832143935338213,0.9957567185289957,1.0,1.0,20/83,20.39%,USP53;ATXN3;MYSM1;OTUD7A;PAN2;USP18;TNFAIP3;CYLD;COPS5;JOSD2;USP49;USP32;USP25;USP21;BRCC3;USP29;OTUD7B;OTUD4;JOSD1;DESI2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.22255274159020771,-0.5829699174926221,0.9567198177676538,0.9854434869288032,1.0,10/20,31.66%,SENP3;OTULINL;USP9X;USP50;OTUB1;SENP5;OTUD5;USP47;YOD1;UFSP2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.20431303418461264,0.5811727429357131,0.9861751152073732,1.0,1.0,18/57,28.15%,NDUFA2;NDUFA8;NDUFA4;CYB561A3;UQCRC1;NDUFA12;NDUFB3;UQCRQ;NDUFC1;COX10;UQCR11;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,endonuclease activity (GO:0004519),0.21092829115632555,0.5807580971764462,0.9859154929577465,1.0,1.0,10/49,18.52%,NTHL1;PIWIL1;MRE11;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1
prerank,pyrophosphatase activity (GO:0016462),0.212169082320228,0.5798383921906337,0.9821693907875185,1.0,1.0,10/50,20.00%,ENTPD1;ENTPD5;NUDT3;DCP2;DXO;NUDT9;DOLPP1;NUDT1;NUDT10;NUDT16
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.27692315390273015,0.5762703032959899,0.9210526315789473,1.0,1.0,2/11,16.37%,NTHL1;HMGA2
prerank,omega peptidase activity (GO:0008242),0.19264229035835015,0.576126293331958,0.9900142653352354,1.0,1.0,22/89,20.58%,USP53;ATXN3;MYSM1;OTUD7A;PAN2;USP18;ASRGL1;TNFAIP3;CYLD;COPS5;JOSD2;USP49;USP32;USP25;USP21;BRCC3;USP29;OTUD7B;OTUD4;JOSD1;DESI2;APEH
prerank,RNA polymerase binding (GO:0070063),-0.23005008915239328,-0.5742636188227849,0.9748110831234257,0.9854259979260205,1.0,5/18,22.26%,CCNT2;PABPN1;BRCA1;TCERG1;NEDD4
prerank,endodeoxyribonuclease activity (GO:0004520),-0.21511379260445182,-0.567169081185819,0.9642857142857143,0.9846834211547374,1.0,5/20,15.89%,RBBP8;ENDOV;ZRANB3;ERCC1;RAD50
prerank,snRNA binding (GO:0017069),0.20851435623232328,0.5617749296673632,0.9787878787878788,1.0,1.0,13/42,25.52%,EFTUD2;SNU13;SNRPC;EIF5A;NCBP2;SNRPB2;PRPF4;CCNT1;LSM4;SF3B3;PRPF8;SNRPA;SART3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2567860988636715,0.5583421533384589,0.9381443298969072,1.0,1.0,5/14,18.87%,MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,microtubule plus-end binding (GO:0051010),0.23219958815032363,0.5507699615519969,0.9663299663299664,1.0,1.0,7/20,21.42%,CLIP1;MAPRE2;MAPRE3;APC;CLIP2;DCTN1;CLASP1
prerank,endoribonuclease activity (GO:0004521),0.21179182046272294,0.5464900471699876,0.9807383627608347,1.0,1.0,13/32,27.51%,PIWIL1;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;RIDA;KHNYN;ZC3H12A;AGO1;ENDOU
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.22898907694593634,0.5414160263300821,0.9694915254237289,1.0,1.0,4/22,19.45%,MESD;AP2M1;DNAJA1;LRPAP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.20770623031140337,0.5394136833393439,0.9836867862969005,1.0,1.0,9/35,21.01%,NT5C3A;PTRH2;ELAC1;DTWD2;GATC;TRMT12;MRPL58;TRMT5;QTRT2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2224086023493657,-0.5377681850243065,0.9644549763033176,0.9912278671181188,1.0,2/15,9.69%,P2RX4;P2RY14
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21724250505601672,0.5344875912393302,0.9802306425041186,1.0,1.0,8/28,21.39%,EDC3;ELAC1;RPP38;MRPL44;RPP21;DICER1;NUDT16;RPP30
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.20094349045563942,0.5317548050872694,0.985781990521327,1.0,1.0,14/37,28.70%,SARS2;SARS1;YARS2;GARS1;TARS3;FARSB;PARS2;CARS1;IARS2;NARS1;HARS1;VARS1;LARS2;MARS2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23255100573339865,0.5286207824845569,0.963302752293578,1.0,1.0,3/18,21.29%,HSD17B7;HSD17B8;HSD17B10
prerank,neuropeptide receptor activity (GO:0008188),0.2108964985859795,0.5247130579610263,0.9851239669421488,1.0,1.0,6/29,23.31%,SORCS1;HCRTR2;NPY5R;SSTR1;GRPR;OPRM1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2511298016570426,0.5225541577053978,0.9345794392523364,1.0,1.0,10/10,74.90%,POLD1;DCLRE1C;EXD2;DCLRE1B;MGME1;DCLRE1A;FEN1;APEX1;EXO1;TATDN1
prerank,telomeric DNA binding (GO:0042162),0.20414196730248818,0.5134362702960265,0.9831649831649831,1.0,1.0,4/32,12.39%,HMBOX1;TERF2;ACD;TERF1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.21399409584825096,0.5091734721738127,0.9796610169491525,1.0,1.0,21/21,78.63%,CHRNB1;GRM5;GRIA1;GRM1;CHRNA2;DRD4;CHRNA6;DRD1;CHRNA1;DRD5;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA7;CHRFAM7A;CHRNA5;CHRNB2;CHRNA4;ANXA9
prerank,acetylcholine receptor activity (GO:0015464),0.21322156547817314,0.5080442025948205,0.9697986577181208,1.0,1.0,2/22,11.27%,CHRNB1;CHRM3
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.21896541168747571,0.4899713028946714,0.9776632302405498,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.21896541168747571,0.4899713028946714,0.9776632302405498,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,androgen receptor binding (GO:0050681),0.19875963697562304,0.4885418437819516,0.9852216748768473,1.0,1.0,13/25,30.26%,PKN1;ZBTB7A;PRKCB;TRIM68;FOXP1;KDM3A;DAXX;CALR;SMARCA4;SNW1;KDM4C;PARK7;PRPF6
prerank,myosin V binding (GO:0031489),0.2250746701438823,0.48803087159983594,0.9805996472663139,1.0,1.0,2/15,10.49%,RAB11A;RAB3B
prerank,NADPH binding (GO:0070402),0.2187078968063608,0.48474357574239607,0.9761029411764706,1.0,1.0,3/13,15.53%,HMGCR;QDPR;LBR
prerank,nuclear import signal receptor activity (GO:0061608),0.21460413134928114,0.4775148285184225,0.9762340036563071,1.0,1.0,15/15,78.56%,RANBP6;IPO4;TNPO2;KPNA4;IPO9;TNPO1;IPO5;TNPO3;KPNA7;KPNA2;KPNA1;KPNB1;HIKESHI;KPNA6;KPNA3
prerank,mRNA 5'-UTR binding (GO:0048027),0.19578175479388613,0.47602244082748413,0.9790322580645161,1.0,1.0,4/24,16.70%,SHMT2;RPS7;CCT5;MYH10
prerank,RNA methyltransferase activity (GO:0008173),-0.17926618496514596,-0.47162299065909635,0.9932279909706546,1.0,1.0,4/19,21.56%,TRMT9B;TGS1;BCDIN3D;LCMT2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.19189761921446497,0.47011047022127483,0.9884488448844885,1.0,1.0,3/22,14.52%,HTR2A;CHRM3;HTR4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.19189761921446497,0.47011047022127483,0.9884488448844885,1.0,1.0,3/22,14.52%,HTR2A;CHRM3;HTR4
prerank,serotonin receptor activity (GO:0099589),0.19189761921446497,0.47011047022127483,0.9884488448844885,1.0,1.0,3/22,14.52%,HTR2A;CHRM3;HTR4
prerank,O-methyltransferase activity (GO:0008171),0.23382659549824247,0.4688102567049483,0.9733333333333334,1.0,1.0,3/10,21.13%,CMTR2;CMTR1;COQ3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.20712536888882196,0.45773985951432433,0.9907407407407407,1.0,1.0,4/15,25.10%,PRDM9;KMT2C;RBBP5;WDR82
prerank,methyltransferase activity (GO:0008168),0.1697034003465243,0.45410405279191224,1.0,1.0,1.0,15/46,28.59%,LCMT1;EEF1AKMT3;NDUFAF7;MGMT;MRM2;COMTD1;PRMT7;COQ3;METTL3;GCSH;TRMT11;EEF1AKMT4;SUV39H1;DNMT3B;DNMT1
prerank,tRNA methyltransferase activity (GO:0008175),0.19947007376839448,0.44589781931108224,0.982363315696649,0.9995046345341707,1.0,7/16,27.02%,TRMT12;METTL2B;METTL2A;ALKBH8;TRMT5;TARBP1;TYW3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.16354846810647916,-0.38402584164668424,1.0,1.0,1.0,14/14,83.67%,CAPN1;CAPN15;CAPN11;CAPN5;CAPN8;CAPN3;CAPNS2;CAPN9;CAPN13;CAPN6;CAPNS1;CAPN10;CAPN12;CAPN2
prerank,proton transmembrane transporter activity (GO:0015078),-0.12564919139751088,-0.381660651932023,1.0,1.0,1.0,14/39,34.96%,SLC9A1;COX6A1;UQCRFS1;SLC33A1;NNT;ATP6V1F;COX6B1;CLCN4;SLC11A2;COX5A;COX4I2;SLC4A11;CYB5A;COX7A1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.15630955994714163,-0.3786175507822966,0.9977777777777778,0.9993032631131844,1.0,4/14,27.17%,PRORP;POP4;TSEN2;POP7
prerank,ribonuclease P activity (GO:0004526),0.1845247985475391,0.37792565304371667,0.994263862332696,1.0,1.0,3/11,21.39%,RPP38;RPP21;RPP30
prerank,cytochrome-c oxidase activity (GO:0004129),0.1565541854145216,0.35355846881930986,0.9964850615114236,1.0,1.0,7/15,32.71%,NDUFA4;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,single-stranded DNA helicase activity (GO:0017116),0.1420586572881995,0.3310312520079424,1.0,0.99977047178696,1.0,19/19,85.81%,DNA2;CHTF18;RFC2;RFC4;WRNIP1;MCM6;HELQ;DHX9;MCM7;MCM2;RAD51;CHTF8;POLQ;PIF1;DSCC1;RFC5;MCM5;RFC3;HELB
